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ABSTRACT OF THE DISSERTATION 
Atrial Arrhythmogenic Substrates: The Role of Structure and Molecular Remodeling 
by 
Christina Marie Ambrosi 
Doctor of Philosophy in Biomedical Engineering 
Washington University in St. Louis, August 2011 
Igor R. Efimov, Chair 
 
 
Atrial tachyarrhythmias, specifically atrial flutter (AFl) and fibrillation (AF), affect over 
2.2 million Americans, leading to more hospitalizations than any other cardiac 
arrhythmia.  These arrhythmias are defined by the presence of reentrant circuits of 
excitation leading to high atrial rates and uncoordinated activation of the ventricles.  The 
underlying mechanisms of AFl/AF have proven complex and, despite a century of 
research, no one effective treatment has been developed.  Surgical ablation and 
pharmacological therapies are both fraught with risks and potential pro-arrhythmic side 
effects.  Electrical cardioversion, on the other hand, is extremely effective in terminating 
these arrhythmias, but the high-energy shocks required for termination cause substantial 
pain to the patient.     
 
In this dissertation, we first investigate the underlying molecular and structural 
mechanisms of AF in two clinically-relevant models – the human and canine hearts.  We 
identify structural and molecular substrates responsible for the generation and 
maintenance of AFl/AF.  We then explore the application of a novel low-voltage 
iii 
defibrillation therapy to a rabbit model of atrial tachyarrhythmias and show significant 
reductions in the defibrillation threshold for both AF and AFl.  We utilize a variety of 
experimental techniques, such as high throughput quantitative PCR, optical coherence 
tomography, and optical mapping.  Only truly integrative approaches to arrhythmia 
research, combining a variety of experimental models and techniques, can continue to 
unravel the complexities of underlying molecular, structural, and electrophysiological 
mechanisms and develop effective, safe therapies, as we demonstrate in this dissertation 
with regards to atrial tachyarrhythmias.   
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1 Introduction 
 
 
 
Atrial fibrillation (AF) affects more than 2.2 million Americans (Lloyd-Jones, Adams et 
al. 2010), a number that continues to grow as the population ages.  By the year 2050 it is 
estimated that between 12 and 16 million Americans may be affected by this condition 
(Miyasaka, Barnes et al. 2006).  In addition to an increased mortality rate, AF also leads 
to more hospitalizations than any other cardiac arrhythmia, resulting in a significant 
socioeconomic burden (Coyne, Paramore et al. 2006; Crandall, Horne et al. 2009; Kannel 
and Benjamin 2009).  Despite over a century of research, no single effective 
pharmacological treatment for AF has been developed (Tamargo, Caballero et al. 2004).  
In addition, surgical ablation procedures are fraught with risks, including, but not limited 
to, esophageal injury, phrenic nerve injury, and pulmonary vein stenosis (Doppalapudi, 
Yamada et al. 2009).  Electrical cardioversion, on the other hand, is extremely effective 
in defibrillating AF (Koster, Dorian et al. 2004), but the high shock energies required for 
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termination can cause cardiac damage (Khan 2003; Fedorov, Kostecki et al. 2008) and 
substantial pain to the patient (Mitchell, Spurrell et al. 2004). 
 
AF can be classified as a progressive disease and, if left untreated paroxysmal AF can 
degenerate into permanent AF (Cohen and Naccarelli 2008), for example, in a process 
personified as “AF begets AF” (Wijffels, Kirchhof et al. 1995).  Understanding the 
electrical, structural, and molecular remodeling associated with this process is ongoing.  
Ultimately, the success of AF therapy depends on a thorough understanding of the global 
mechanisms of this complicated, confounding arrhythmia. 
  
The work presented in this dissertation will seek to further understand the molecular and 
structural substrates of atrial fibrillation and then explore the application of a novel 
defibrillation therapy to a rabbit model of atrial tachyarrhythmias.  A variety of 
experimental techniques, including high-throughput quantitative PCR, optical coherence 
tomography, and optical mapping will be applied in this investigation. 
 
 
1.1 Historical Identification of Atrial Fibrillation 
 
 
The earliest record of atrial fibrillation is believed to be located in The Yellow Emperor’s 
Classic of Internal Medicine composed over two millennia ago (Lip and Beevers 1995).  
The first description of auricular fibrillation, now more commonly known as AF, is, 
however, credited to Sir William Harvey in 1628 (McMichael 1982). After Harvey’s 
initial description of the arrhythmia, it was not until the late nineteenth century that the 
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first pulse tracings of patients in atrial fibrillation were recorded and identified as such 
(Silverman 1994; Khasnis and Thakur 2009).  The first electrocardiographic 
identification followed shortly thereafter and was published in 1909 by Thomas Lewis.  
The arrhythmia was described as “pulsus inaequalis and irregularis” and the ECG, shown 
in Figure 1.1, showed a distinct lack of p-waves, which would have represented normal 
atrial activity, exhibiting instead a jagged series of fibrillatory waves termed f-waves 
(Lewis 1909). 
 
 
Figure 1.1: Electrocardiograms recorded by Thomas Lewis, 1912.  Top, a patient in 
normal sinus rhythm. Bottom, a patient in atrial fibrillation displaying f-waves (Lewis 
1912a). 
 
 
 
1.2 Elucidating the Mechanisms of Atrial Fibrillation 
 
 
Despite more than a century of research, the mechanisms of atrial fibrillation remain 
unclear.  Initially, AF was thought to arise due to rapid focal activity in one (or more) 
atrial locations (Lewis 1912b).  In 1913, however, George Mines proposed that 
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fibrillatory waves are caused by reentrant circuits in tissue with specific refractory 
characteristics (Mines 1913), as illustrated in Figure 1.2.  
   
 
Figure 1.2: Concept of reentry proposed by George Mines, 1913.  (a) Nonsustained 
reentry.  (b) Sustained reentry (Mines 1913). 
 
 
In 1921, Lewis and colleagues formulated a “mother ring” theory, which suggested that a 
single reentrant circuit is sufficient to maintain atrial fibrillation.  This theory was later 
developed into the modern-day “mother rotor” hypothesis and has since been 
demonstrated experimentally (Mandapati, Skanes et al. 2000).  In contrast to the “mother 
rotor” hypothesis, Walter Garrey and later Gordon Moe suggested that multiple reentrant 
waves, as opposed to one main rotor, are necessary for the maintenance of AF (Garrey 
1924; Moe 1968).  Maurits Allessie has since provided compelling experimental evidence 
supporting this latter theory (Allessie, Lammers et al. 1985).  In addition, more recent 
clinical evidence in support of the original focal activation theory has been presented by 
Michel Haissaguerre and colleagues (Haissaguerre, Jais et al. 1998).  Focal activity has 
since been shown to arise from the pulmonary veins (Haissaguerre, Jais et al. 1998), 
superior vena cava (Li and Wang 2006), coronary sinus (Haissaguerre, Hocini et al. 
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2006), and the vein of Marshall (Chen, Chou et al. 2006).  In addition, the autonomic 
basis of atrial fibrillation has also been explored (Coumel 1994a).  
 
 
1.2.1 Critical Mass Hypothesis 
 
 
The maintenance of a reentrant arrhythmia also relies upon a critical mass of tissue 
required for fibrillation.  This theory was first proposed by William Garrey in 1914, 
during his tenure at Washington University.  In that study, Garrey found that by 
progressively diminishing the size of cardiac tissue, fibrillation could eventually no 
longer be sustained (Garrey 1914).  The subsequent development of the maze procedure 
for surgical treatment of atrial fibrillation, also developed at Washington University, was 
based on this concept (Cox and Sundt 1997).  By dividing the fibrillating atrium into 
smaller units while still allowing for normal sinus node activation, this procedure 
eliminates the minimum path length needed to sustain reentry in fibrillation (Weiner and 
Rosenbluth 1946). 
   
1.2.2 Atrial Remodeling in Fibrillation 
 
 
Atrial fibrillation is accompanied by both short- and long-term remodeling processes 
(Brundel, Henning et al. 2002), which makes it increasingly difficult to convert to and 
maintain normal sinus rhythm with either pharmacological agents or cardioversion, the 
longer the arrhythmia persists (Van Gelder, Crijns et al. 1991; Coro, Delise et al. 2001).  
Experimental and clinical studies point to both electrical and structural remodeling as the 
cause of this maladaptation (Wijffels, Kirchhof et al. 1995; Ausma, Wijffels et al. 1997). 
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Immediate short-term changes in the atrial substrate include functional changes in the L-
type calcium channel (ICa,L) (Yue, Feng et al. 1997) accompanied by concurrent changes 
in protein-level expression of the channel subunits (Van Wagoner, Pond et al. 1999; 
Brundel, Van Gelder et al. 2001a).  This reduction in ICa,L results in a marked decrease of 
the atrial effective refractory period (ERP) and detrimental changes in action potential 
rate adaptation (Wijffels, Kirchhof et al. 1995).  Longer-term changes associated with AF 
include, in addition to persistently reduced levels of ICa,L, marked reductions in the 
expression of repolarizing potassium channels (Brundel, Van Gelder et al. 2001a; 
Brundel, Van Gelder et al. 2001b).  Although it has been shown that the primary 
electrophysiological changes during AF are due to the reduction in ICa,L (Yue, Feng et al. 
1997; Brundel, Van Gelder et al. 2001a), the concomitant reductions in potassium 
currents are thought to be an adaption of the atrial cells to these overall detrimental 
changes (Brundel, Van Gelder et al. 2001a).  The long-term, persistent alterations in these 
(and other) ion channels, which directly affect the atrial electrophysiological properties, 
play an important role in the continued susceptibility to the reinduction of AF even after 
restoration of normal sinus rhythm. 
 
In addition to molecular-level remodeling of ion channels and their resulting effects on 
basic electrophysiological parameters, AF is also accompanied by the development of 
structural abnormalities.  For instance, in a goat model of rapid atrial pacing-induced AF 
up to 92% of atrial myocytes exhibited mitochondrial enlargement, glycogen 
accumulation, and loss of myofibrils (Ausma, Wijffels et al. 1997).  A similar study in 
human atrial myocytes showed that patients with persistent AF exhibited the most 
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pronounced structural changes (Mary-Rabine, Albert et al. 1983).  In addition, increased 
atrial fibrosis can lead to the continued generation and maintenance of AF (Pellman, 
Lyon et al. 2010).  Taken together, these electrophysiological, molecular, and structural 
changes create overall tissue heterogeneities, which can further effect atrial ERPs and 
continue the promotion of AF in the cycle termed “AF begets AF” (Wijffels, Kirchhof et 
al. 1995). 
 
 
1.3 Atrial Fibrillation and Atrial Flutter 
 
 
AF typically involves multiple reentrant circuits defined by both local tissue 
heterogeneities and electrophysiological properties.  Classic atrial flutter (AFl), on the 
other hand, is typically defined by a macro-reentrant circuit rotating around an 
anatomical and/or functional line of block.  Major anatomical structures, including the 
region between the vena cavae and pulmonary veins, are usually involved in defining 
reentry (Fedorov, Chang et al. 2010).  It is also well-known from the seminal studies in 
atrial tachyarrhythmias that AF can revert to AFl and vice versa (Garrey 1924).  More 
recent investigations have defined the inter-relationships between these two arrhythmias 
and have shown that in most cases AF, of variable durations, precedes most instances of 
AFl and is instrumental in creating the functional line of block between the vena cavae 
responsible for the subsequent maintenance of AFl (Waldo 2003).  Although molecular 
remodeling associated with AFl has not been investigated in detail, a recent study has 
shown that patients with occasional episodes of AFl did indeed exhibit structural and 
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functional atrial abnormalities that may also predispose them to the eventual development 
of permanent AF (Stiles, Wong et al. 2010). 
 
Treatment options for AFl are similar to those for AF specifically with respect to both 
rhythm and rate control (Dhar, Lidhoo et al. 2009).  Pharmacological treatments are often 
utilized to maintain normal sinus rhythm and control fast and/or irregular ventricular rates 
(Van Gelder, Tuinenburg et al. 1999).  Electrocardioversion of AFl has success rates 
close to 100% and rapid pacing protocols, also known as antitachycardia pacing, can also 
be used to interrupt the reentrant circuits maintaining the arrhythmia, although its 
published success rates are variable (Van Gelder, Tuinenburg et al. 1999; Koster, Dorian 
et al. 2004).  Finally, ablation is also an option for severely symptomatic patients whose 
rate and rhythm cannot be controlled by other means (Dhar, Lidhoo et al. 2009).   
 
 
1.4 Atrial Fibrillation and Heart Failure 
 
 
Congestive heart failure (CHF) affects 5.8 millions Americans (Lloyd-Jones, Adams et 
al. 2010) and is associated with any number of comorbidities, including AF.  In fact, 25% 
of heart failure patients will develop AF within five years of their initial diagnosis 
(Wang, Larson et al. 2003) and its prevalence increases with increasing severity of CHF 
(Maisel and Stevenson 2003).  In addition, within five years of being diagnosed with AF, 
15% of all patients will develop heart failure (Wang, Larson et al. 2003).  Not only does 
the development of one condition increase the risk of developing the other, but there is 
also an increased mortality risk with the development of both AF and CHF (Wang, 
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Larson et al. 2003).  Consequently, there is a complex interplay of factors predisposing 
patients with AF to CHF and vice versa. 
 
In CHF, atrial pressure and volume overload contribute to the development of atrial 
enlargement which can directly effect atrial electrophysiological parameters, including 
dispersion of refractory properties (Maisel and Stevenson 2003).  In addition, 
neurohormonal activation can affect the synthesis and degradation of the extracellular 
matrix thus creating the substrate necessary for the generation and maintenance of AF 
(Tomaselli and Marban 1999).  Conversely, in AF the loss of atrio-ventricular synchrony 
and development of an irregular ventricular response eventually lead to the long-term 
remodeling processes associated with CHF (Boyle and Shivkumar 2009). 
 
 
1.5 Tools for Understanding the Structure-Function 
Relationship of Atrial Flutter and Fibrillation 
 
 
The investigations presented in this dissertation were completed through the use of 
various experimental models and techniques.  We used human and canine models to 
elucidate the molecular and structural mechanisms of atrial tachyarrhythmias, as well as a 
rabbit model to explore a novel method for low-voltage termination of AF and AFl.  To 
accomplish these tasks we applied several experimental techniques, including high 
throughput quantitative PCR, optical coherence tomography, and optical mapping. 
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1.5.1 Experimental Models 
 
 
 
1.5.1.1 Human 
 
 
Over the last four and a half years, we have developed the infrastructure necessary to 
collect human hearts for both functional- and structural-level analyses.  For the projects 
contained within this dissertation, we have received hearts from two sources: (1) 
nonfailing donor hearts rejected for cardiac transplantation from Mid-America Transplant 
Services (St. Louis, Missouri) and (2) failing hearts from transplant recipients at Barnes-
Jewish Hospital (St. Louis, Missouri).  The wide spectrum of clinical characteristics, as 
shown in Figure 1.3, in the hearts we have collected provides the basis for investigating 
the structural and molecular components important in both normal and abnormal cardiac 
conduction. 
 
 
 
Figure 1.3: Summary of human heart clinical characteristics (n=128). 
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1.5.1.2 Dog 
 
 
Canine cardiac models, on the other hand, have the distinct advantages of being more 
readily available, as well as similar in size to the human heart.  Recent studies from our 
group have also demonstrated the functional similarity of the human and dog sinoatrial 
nodal conduction patterns (Fedorov, Schuessler et al. 2009; Fedorov, Glukhov et al. 
2010).  Since canine hearts are more reliably available than human hearts, we have 
consequently used a canine model in our investigation of the structure of the atrial 
pacemaker complex. 
 
 
 
1.5.1.3 Rabbit 
 
 
The Langendorff-perfused rabbit heart as an experimental model for the defibrillation of 
AF and AFl offers several unique advantages to our study.  First and foremost, this 
species has been proven to be the most suitable model for in vitro research of 
defibrillation due to its ability to sustain clinically-relevant arrhythmias, which are not 
typically observed in smaller species (Panfilov 2006).  In addition, the size of the rabbit 
atria allows for thorough reconstruction of electrical activity throughout the thickness of 
the intact heart using optical techniques.  Finally, its atrial tachyarrhythmias are similar to 
clinically-observed paroxysmal forms of vagal-related “lone-AF” (Coumel 1994b). 
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1.5.2 Experimental Techniques 
 
 
1.5.2.1 Quantitative PCR 
 
 
Polymerase chain reaction (PCR), developed in 1983, is a commonly-used technique for 
the amplification and detection of DNA (Bartlett and Stirling 2003).  Real-time PCR, also 
known as quantitative PCR (qPCR), is used to simultaneously amplify and quantify target 
DNA sequences based on the use of fluorescent probes (VanGuilder, Vrana et al. 2008).  
Probes can either be non-specific, in which case they will bind to any double stranded 
DNA molecule, or specific, in which case they bind directly to a desired DNA sequence.  
In this investigation, we have used Taqman probes, which consist of a reporter and 
quencher molecule attached to each end of a specific oligonucleotide sequence (Holland, 
Abramson et al. 1991).  When the reporter and quencher are in close proximity (i.e., 
attached to the 5’ and 3’ ends of the probe), fluorescence is quenched.  When the reporter 
and quencher are separated (i.e., during primer extension by the Taq polymerase), 
fluorescence is emitted.  Consequently, at each stage of the amplification process, 
product can be quantified based on the increasing amount of fluorescence in the system.  
This process is illustrated in Figure 1.4. 
 
 
Figure 1.4: Mechanism of qPCR using the Taqman probe (Bustin 2000). 
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The amplification process proceeds in three phases: (1) the exponential phase during 
which PCR product doubles after each cycle, (2) the linear phase during which reagents 
begin to run out and the process slows, and (3) the plateau phase during which reagents 
are depleted and the reaction stops.  The exponential phase consequently yields the most 
useful information for subsequent analysis.  As shown in Figure 1.5, during the 
exponential phase of amplification a threshold is established (as shown by the green line), 
which represents a level for detection above the background fluorescence. A threshold 
cycle, more commonly referred to as the Ct, is then automatically specified.  Analysis 
proceeds using the Ct relative quantification method (Livak and Schmittgen 2001) with a 
chosen endogenously-expressed control gene. 
 
 
Figure 1.5: Example qPCR amplification plot.   
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1.5.2.2 Optical Coherence Tomography 
 
 
Optical coherence tomography (OCT) was first introduced in 1991 and used to visualize 
the retina and coronary arteries (Huang, Swanson et al. 1991).  Since then it has gained 
prominence as a diagnostic imaging modality in the fields of ophthalmology (Costa, Skaf 
et al. 2006; Chang and Budenz 2008; Drexler and Fujimoto 2008), vascular cardiology 
(Pinto and Waksman 2006; Tearney, Jang et al. 2006; Brezinski 2007; Guagliumi and 
Sirbu 2008), and dermatology (Welzel 2001; Gambichler, Moussa et al. 2005).  In 
biological specimens, OCT boasts resolutions of submicrometer through 15 µm, which 
can be 10 to 100 times greater than other modalities, such as MRI and ultrasound 
(Povazay, Bizheva et al. 2002; Fujimoto 2003).  OCT is, however, limited by its depth 
penetration, estimated to be 2 to 3 mm in nontransparent biological tissues (Fujimoto 
2003). 
 
OCT, based on the principle of low-coherence interferometry, measures the backscatter 
of light reflected from within the depth of nontransparent tissues, as shown in Figure 1.6.  
Signal intensity is determined by the amplitude and coherence of the reflected waves in 
comparison with light reflected along a reference arm of known length.  Resulting scans 
consequently create high resolution, non-invasive tissue biopsies.  We have termed this 
technique “virtual histology”. 
 
A typical OCT data set is shown in Figure 1.7.  In this example, a trabeculation from the 
human right atrial endocardium is being imaged (Figure 1.7A).  Figure 1.7B shows an 
example A-scan, or virtual slice, taken perpendicular to the tissue surface.  In total, 400 
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two-dimensional virtual slices are recorded and then reconstructed into a three-
dimensional virtual piece of tissue as shown in Figure 1.7C.  Subsequently, the virtual 
tissue can be sliced in any desired direction.  In this dissertation, we are most interested in 
visualizing and quantifying fiber orientation.  Consequently, we can virtually slice the 
tissue parallel to the surface and visualize the underlying cardiac fibers, as shown in 
Figure 1.7D. 
 
Figure 1.6: Principles of OCT.  (a) The setup for our bench top OCT system includes a 
light source feeding directly into a 50/50 coupler splitting light between the reference 
and sample arms.  The reflected light is then sensed by the detector, filtered, and 
amplified before advancing to the frame grabber.  (b) An example A-scan describing the 
intensity of the reflected light at various depths in the tissue.  (c) Multiple A-scans create 
the final image slices, or 2-D tomogram (B-scan). 
   
 
Figure 1.7: Typical OCT data set.  (A) Atrial trabeculations of the RA appendage as 
viewed from the endocardium. (B) 2-D virtual slice of tissue.  (C) 3-D OCT rendering of 
the trabeculations.  (D) Fiber architecture located 0.44 mm below the surface. 
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1.5.2.3 Optical Mapping 
 
 
Optical mapping, first used to record cardiac electrical activity in 1976 (Salama and 
Morad 1976), has provided a wealth of information regarding cardiac conduction.  This 
technique, first applied in earlier studies with the squid axon (Davila, Salzberg et al. 
1973; Cohen, Salzberg et al. 1974), is based on the use of voltage-dependent fluorescent 
molecules and allows one to record electrical activity from hundreds to thousands of sites 
simultaneously in a single preparation.  In short, a voltage-sensitive fluorophore is 
inserted into the excitable cell membrane and, upon excitation by an appropriate 
wavelength of light, exhibits changes in its emission spectra proportional to changes in 
the cell transmembrane potential (Ross, Salzberg et al. 1977; Morad and Salama 1979).  
Consequently, these changes in fluorescence mimic the cardiac action potential and 
experimentally are known as the optical action potential.  The most commonly used 
voltage-sensitive dye for cardiac applications is di-4-ANEPPS, a member of the styryl 
family of dyes (Fluhler, Burnham et al. 1985). 
 
A typical optical mapping setup as used in this dissertation is shown in Figure 1.8.  It 
consists of a Langendorff- or coronary-perfused cardiac preparation stained with a 
voltage-sensitive dye, in this case di-4-ANEPPS.  The heart is then illuminated by light-
emitting diodes (LEDs) at 520 nm and fluorescence emitted by the preparation is long-
pass filtered at 610 nm before being recorded by a 100x100 MiCAM Ultima-L CMOS 
camera.  Optical action potentials are then digitized, normalized, and filtered before being 
reconstructed as cardiac electrical activity.     
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Figure 1.8: Typical optical mapping setup. 
 
During cardiac optical mapping, one must also consider the confounding contribution of 
motion artifacts to the optical signals.  Consequently, both pharmacological agents 
(Cheng, Mowrey et al. 1997; Biermann, Rubart et al. 1998) and mechanical strategies 
(Salama and Choi 2000) have been employed to remove these effects.  Unfortunately, 
such agents as 2,3-butanedione monoxime (BDM) and cytochalasin-D, have been shown 
to have nonspecific effects that can further distort the interpretation of physiological 
experiments (Cheng, Li et al. 2004; Kettlewell, Walker et al. 2004).  More recently, a 
specific inhibitor of the ATPases associated with myosin II isoforms, was characterized 
by our group and has since been shown to have no significantly detrimental effects on 
cardiac parameters in a variety of species, including mouse, rabbit, dog, and human 
(Fedorov, Lozinsky et al. 2007).    
 
 
1.6 Scope and Procedure of the Dissertation 
 
 
In this dissertation, we first explore the molecular and structural mechanisms associated 
with atrial flutter and fibrillation and then test a novel method for terminating these atrial 
tachyarrhythmias.  We employ a variety of experimental techniques and models as 
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discussed in this Introduction.  Chapter 2 will present a study in which we explore 
gender-dependent molecular remodeling that occurs in the setting of both atrial 
fibrillation and congestive heart failure using human tissues and high-throughput 
quantitative PCR techniques.  In addition to probing gene targets in atrial tissues, we also 
investigate remodeling in the ventricle in the setting of ventricular tachyarrhythmias and 
heart failure.  Chapters 3 and 4 will present our evaluation of optical coherence 
tomography in high-resolution imaging of the cardiac conduction system and other 
structures in the explanted human and canine hearts.  Chapter 3 focuses on imaging 
various elements of the human heart, whereas Chapter 4 focuses specifically on imaging 
and quantifying fiber structure in the canine atrial pacemaker complex, which is an active 
participant in the generation and maintenance of both atrial flutter and fibrillation.  
Finally, Chapter 5 will explore a novel method for low-voltage defibrillation of atrial 
flutter and fibrillation.  Chapter 6 will then present final conclusions and future directions 
of the larger investigation.  
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2 Gender Dependent Differences in Molecular 
Electrophysiological Targets in Failing and 
Nonfailing Human Hearts 
 
 
 
2.1 Abstract 
 
 
Previous epidemiological studies have shown that males tend to have an increased overall 
lifetime risk of developing atrial fibrillation, whereas females tend to be more susceptible 
to the development of ventricular tachyarrhythmias resulting from long-QT syndrome 
and drug-induced Torsades de Pointes.  In this study, we compare transcript-level 
expression of 89 ion channel subunits, calcium handling proteins, and other transcription 
factors important in cardiac conduction and arrhythmogenesis in the left atria (LA) and 
ventricles (LV) of human hearts of both genders.  Total RNA from failing male (n=9), 
failing female (n=7), nonfailing male (n=9), and nonfailing female (n=9) hearts was 
probed using a custom-designed gene array.  Analyses were performed to explore the 
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relationships between gender, failure state, and compartmental expression.  Hierarchical 
cluster analysis revealed expression patterns with chamber specificity, but not overall 
disease or gender dependent clustering.  Gender-specific analysis of the LA showed that 
females exhibited significant reductions in Kv4.3, KChIP2, Kv1.5, and Kir3.1, as 
compared with males.  On the other hand, gender specific analysis of LV targets 
associated with repolarization did not reveal significant differences or patterns based on 
gender.  Overall, our data highlight the differential expression and transcriptional 
remodeling of ion channel subunits in the human heart as a function of gender and 
cardiac disease.  Continued access to and analysis of human cardiac tissues, such as those 
studied here, is consequently critically important in increasing our understanding of 
gender dependent differences in the pathogenesis of disease and susceptibility to 
arrhythmias. 
 
 
2.2 Introduction 
 
 
Epidemiologically, there are well-established differences in the manifestations of cardiac 
arrhythmias across gender.  Men are typically more susceptible to the development of 
atrial fibrillation (AF) (Kannel, Wolf et al. 1998; Wolbrette, Naccarelli et al. 2002), 
whereas women have higher incidences of long-QT syndrome (LQTS) and drug-induced 
Torsades de Pointes (Locati, Zareba et al. 1998; Abi-Gerges, Philp et al. 2004).  In 
addition, men and women also exhibit differences in basic electrophysiological 
parameters during normal sinus rhythm.  Women tend to have increased resting heart 
rates (Burke, Goldberger et al. 1996) and longer rate-corrected QT (QTc) intervals 
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(Kligfield, Lax et al. 1996), and men have been reported to have longer P-waves 
suggesting differences in atrial electrophysiology (Dhala, Underwood et al. 2002).  
Interestingly, autonomic blockade does not mask the gender difference in resting heart 
rate, suggesting that intrinsic sinus node differences as opposed to gender dependent 
autonomic tone are responsible for this variability (Burke, Goldberger et al. 1996).  
 
Not as much is known about the molecular mechanisms underlying these gender 
differences in arrhythmia susceptibility and basic electrophysiological parameters in the 
human heart.  Insight has been gained, however, from various animal models, including 
the rabbit, dog, and mouse (James, Choisy et al. 2007).  The rabbit heart has been shown 
to be a relevant model for the study of human arrhythmias (Panfilov 2006) and female 
rabbits also exhibit the same gender dependent QTc prolongation (Ebert, Liu et al. 1998; 
Lu, Remeysen et al. 2001) as is present in the human heart (Kligfield, Lax et al. 1996).  
Mice, although useful from a genetic manipulation standpoint, manifest profound 
differences in their action potential as compared to the human (Nerbonne 2004; Ahrens-
Nicklas and Christini 2009) and must be carefully considered when extending 
conclusions to human pathologies (Glukhov, Flagg et al. 2010; Fedorov, Glukhov et al. 
2011). 
 
Since cardiac conduction and arrhythmia susceptibility are determined by characteristic 
expression profiles of ion channels and other transporters, several studies to date have 
begun to explore gene expression patterns in the human heart (Borlak and Thum 2003; 
Gaborit, Le Bouter et al. 2007; Chandler, Greener et al. 2009; Nattel, Frelin et al. 2009; 
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Gaborit, Varro et al. 2010; Gronich, Kumar et al. 2010).  The ever-present limitation to 
these studies, however, is the availability of human tissues for analysis.  We have 
consequently developed the infrastructure necessary to collect tissues from a wide variety 
of both failing and nonfailing human hearts for use in this study.   
 
We focused on probing tissues of the LA and LV as left-sided heart failure is the most 
common manifestation of this disease (McKee, Castelli et al. 1971).  We subsequently 
explored the expression of 89 target genes in the LA and LV of failing and nonfailing 
human hearts of both genders.  We also have probed tissues from the epicardium and 
endocardium of the LV since we have previously shown that heart failure may result in a 
heterogeneous dispersion of repolarization across the ventricular wall (Glukhov, Fedorov 
et al. 2010), which may also be pro-arrhythmic (Antzelevitch 2007). 
 
 
2.3 Materials and Methods 
 
 
2.3.1 Human Tissue Samples 
 
 
The use of human hearts for research was approved by the Institutional Review Board at 
Washington University in St. Louis.   
 
For this study, a total of 34 explanted human hearts of both genders (n=16 women, 52±10 
years old; n=18 men, 52±14 years old) were acquired from two sources (Figure 2.1).  
Failing human hearts (n=16; 9 men, 7 women) were obtained at the time of cardiac 
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transplantation at Barnes-Jewish Hospital (St. Louis, Missouri) and nonfailing hearts 
(n=18; 9 men, 9 women) were provided by Mid-America Transplant Services (St. Louis, 
Missouri) after they were deemed unsuitable for cardiac transplantation.  Each heart was 
immediately perfused with and stored in cardioplegic solution (4°C) for preservation 
during the 15-20 minute delivery from the operating room to the research laboratory.  
Upon arrival, tissue samples from the LA (n=22) and LV (n=22) free walls (Figure 2.2A) 
were immediately harvested.  Epicardial and endocardial samples were also harvested 
from the LV free wall (n=12) as shown in Figure 2.2B.  All tissue samples were stored in 
RNAlater (Sigma-Aldrich, St. Louis, Missouri) at -80°C.  Relevant clinical 
characteristics of the patients are shown in Table 2.1 for nonfailing hearts and Table 2.2 
for failing hearts. 
 
 
 
Figure 2.1: Study population (n=34).   
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Figure 2.2: Tissue sample locations in the human heart.  (A) Anterior view of a typical 
heart after harvest with the locations for the LA and LV samples marked by the white 
squares.  (B) Left ventricular wedge preparation from which the epicardial and 
endocardial samples were taken as indicated. 
 
 
 
 
Table 2.1: Clinical characteristics of the nonfailing human hearts. 
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Table 2.2: Clinical characteristics of the failing human hearts. 
 
 
 
 
2.3.2 RNA Extraction and Preparation 
 
 
Total RNA was extracted from 68 samples using the RNEasy Fibrous Tissue Mini Kit 
(Qiagen, Valencia, California) according to the manufacturer’s instructions.  RNA yield 
was measured using a Nanodrop 1000 (Thermo Scientific) and quality was assessed by 
verifying the presence of the 18S and 28S bands as run on a 1% agarose gel (Figure 2.3). 
 
 
 
Figure 2.3: RNA quality assessment. 
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2.3.3 Low-Density Taqman Gene Arrays 
 
 
Custom-designed low-density Taqman gene arrays (Applied Biosystems, Foster City, 
California) were then used to probe for the presence of 96 targets in a two-step process as 
described previously (Marionneau, Couette et al. 2005; Gaborit, Le Bouter et al. 2007; 
Gaborit, Varro et al. 2010).  In short, total RNA (1-2 µg) was first converted to cDNA 
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 
City, California).  Subsequent reactions were performed, using 100 ng of cDNA loaded 
into each well of our custom-designed gene arrays, with the ABI PRISM 7900HT 
Sequence Detection System (Applied Biosystems, Foster City, California).  Genes 
selected for analysis included 56 ion channels and accessory proteins, 14 calcium-
handling proteins, 9 autonomic receptors, 6 transcription factors, 3 signaling proteins, and 
8 controls/marker genes and are listed in Appendix A.   
 
 
2.3.4 Statistics and Data Analysis 
 
 
Data were collected and analyzed by the Applied Biosystems SDS 2.3 software using the 
threshold cycle (Ct) relative quantification method (Livak and Schmittgen 2001) with 
GAPDH as an endogenous control.  Quantitative data are expressed as mean ± standard 
deviation.  Statistically significant differences were identified using a one-way analysis of 
variance followed by Tukey-Kramer’s test with a significance level of p<0.05.   All 
quantitative results are listed in Appendix A. 
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In addition, two-way hierarchical agglomerative cluster analysis was performed using the 
ΔΔCt of each target. We applied average linkage clustering with calculation of the 
Euclidean distances.  Clusters were analyzed and visualized using Cluster 3.0 and 
Treeview software (Eisen, Spellman et al. 1998). 
 
 
2.4 Results 
 
 
2.4.1 Hierarchical Cluster Analysis 
 
 
Hierarchical cluster analysis is an unsupervised algorithm used to both visualize and 
explore relationships within large sets of data.  In this study, this technique was used to 
determine if there existed strong enough overall trends across gender, disease, and 
compartmental expression to create distinct clusters of highly related samples.  As is 
shown in Figure 2.4A, LA and LV samples from ischemic and nonfailing hearts of both 
genders show distinct clustering based on their chamber location.  These samples did not 
cluster, however, based on either gender or disease state.  We also explored cluster 
analysis of ischemic, nonischemic, and nonfailing LV samples of both genders, as well as 
nonischemic and nonfailing samples from the epicardium and endocardium of the LV.  
As is evident in Figure 2.4B-C, we did not see clustering of these latter samples based on 
gender, disease, or cardiac location.  
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Figure 2.4: Hierarchical cluster analysis.  (A) Cluster analysis of ischemic and 
nonfailing LA/LV samples of both genders showing distinct separation based on cardiac 
location.  (B) Cluster analysis of ischemic, nonischemic, and nonfailing LV samples 
showing no clustering.  (C) Cluster analysis of nonischemic and nonfailing epicardial/ 
endocardial samples also showing no clustering. 
 
 
 
2.4.2 Ventricular Remodeling in Heart Failure 
 
 
Studies have revealed that during the heart failure remodeling process, the cardiac action 
potential is significantly prolonged and conduction is slowed due to pathological changes 
in the expression and function of ion channels (Janse 2004; Aiba and Tomaselli 2010). 
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As shown in Figure 2.5, we observe significant reductions and trends for reduction in the 
transcript-level expression of ion channel subunits important in cardiac conduction and 
repolarization, as well as changes in key calcium handling proteins.  As confirmed in 
previous studies, we observe significant downregulation of subunits encoding for IKATP 
(Flagg and Nichols 2005) and Ito (Kaab, Dixon et al. 1998; Zicha, Xiao et al. 2004).  Ito, 
in particular, encoded by the pore-forming subunit Kv4.3 and the accessory protein 
KChIP2, is one of the most consistently altered ion channels during the heart failure 
remodeling process across species (Zicha, Xiao et al. 2004).  In addition, it has been 
reported that reduction of Ito is linked to protein-level downregulation of Kv4.3 and 
transcript-level downregulation of KChIP2 (Soltysinska, Olesen et al. 2009), which is 
also reflected in our transcript-level expression data.  We observe no significant changes 
in IK1, INa, and ICa,L, although their function and patterns of expression during heart failure 
are still controversial (Aiba and Tomaselli 2010).  We also observe a trend for reduction 
of Kv11.1/HERG, the subunit encoding for the repolarization current IKr, and trends with 
respect to the calcium handling proteins, SERCA2a and NCX1, consistent with recent 
findings (Soltysinska, Olesen et al. 2009).  Finally, we observe a significant 
downregulation of connexin 43 in nonischemic, but not ischemic, cardiomyopathy.  In 
addition to global downregulation of connexin 43, impaired conduction in heart failure 
may also be due to an altered distribution of the protein in the cell membrane (Akar, Nass 
et al. 2007).        
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Figure 2.5: Ventricular remodeling in heart failure.  The asterisks (*) indicate p<0.05. 
 
 
The general agreement of our findings, regarding ventricular remodeling during heart 
failure, with previous studies both supports the validity of our findings and allows for the 
exploration of other novel gene expression patterns with regards to gender and 
arrhythmia susceptibility. 
 
 
2.4.3 Regional Specificity of Target Expression 
 
 
Major atrial-ventricular expression differences are shown in Figure 2.6.  We confirm 
known predominantly atrial transcripts, such as connexin 40, TASK-1, TWIK-1, Kir2.1, 
Kv1.5, Kir3.1, Cav3.1, and sarcolipin (Ellinghaus, Scheubel et al. 2005; Nattel, Frelin et 
al. 2009; Shanmugam, Molina et al. 2011).  In addition, with the exception of atrial 
connexin 40, we show relatively consistent transcript-level expression of connexin 40, 
45, and 43 in the both the LA and LV.  Because this is not reflective of protein-level 
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expression patterns (Vozzi, Dupont et al. 1999; Severs, Bruce et al. 2008), it is important 
to note that within the realm of this study and other transcript-level investigations, post-
translational modifications may play an important role in final functional expression and 
specificity. 
 
Figure 2.6: Regional specificity in failing and nonfailing hearts. The asterisks (*) 
indicate p<0.05. 
 
 
 
2.4.3.1 Regional Specificity of IKATP Subunits  
 
 
ATP-sensitive potassium (KATP) channels are prominent in cardiac sarcolemmal 
membranes and their activation during myocardial ischemia and hypoxia results in an 
enhanced potassium efflux, reduction in action potential duration, and reduced 
refractoriness (Noma 1983; Wilde, Escande et al. 1990; Zhang, Flagg et al. 2010).  
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Consequently, their activation during an ischemic insult plays an important role in 
cardioprotection, but also may promote ventricular fibrillation (Padrini, Bova et al. 1992).  
Sarcolemmal KATP channels are composed of a pore-forming subunit (Kir6.1 or Kir6.2) 
and a sulfonylurea receptor (SUR1, SUR2A, or SUR2B) (Pountney, Sun et al. 2001; 
Chan, Wheeler et al. 2008).  The SUR subunit determines the specificity and selectivity 
against KATP agonists and antagonists (Liu, Ren et al. 2001).  In mouse isolated cells 
(Flagg, Kurata et al. 2008) and whole hearts (Glukhov, Flagg et al. 2010), it has been 
shown that atrial KATP is only sensitive to the KATP channel opener diazoxide, which is 
specific to SUR1 and not to pinacidil, which is specific to SUR2A.  On the other hand, 
ventricular KATP channels were shown to have the opposite sensitivity to these channel 
openers.  The few published studies on human KATP channels have focused either on 
isolated single cells (Koumi, Martin et al. 1997; Pelzmann, Schaffer et al. 2001; Balana, 
Dobrev et al. 2003; Wu, Huang et al. 2005; Raeis, Philip-Couderc et al. 2010) or fibers 
(Gautier, Bertrand et al. 1991) and to date there has been little information regarding the 
chamber specificity of KATP channel openers in the human heart. 
 
In our recently published study, we functionally assessed the effects of the KATP channel 
openers, diazoxide and pinacidil, in coronary-perfused human atrio-ventricular 
preparations (Fedorov, Glukhov et al. 2011).  In short, we found that both pinacidil and 
diazoxide affected the action potential duration (APD) in all chambers of both failing and 
nonfailing human hearts as shown in Figure 2.7.   
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Figure 2.7: Effect of KATP channel openers on the action potential duration in isolated 
human hearts.  From Fedorov, Glukhov, Ambrosi, et al. JMCC. 2011. 
 
 
As a complement to the functional data collected using optical mapping in this study, we 
also analyzed transcript-level expression of the KATP channel subunits (Kir6.1, Kir6.2, 
SUR1, and SUR2), which were part of our larger molecular electrophysiological 
investigation.  In choosing primers, we did not distinguish between SUR2A and 2B.  As 
shown in Figure 2.8, all targets were expressed in both chambers with no obvious 
chamber specificity of either the channels or their subunits, which had been previously 
found in the mouse heart (Glukhov, Flagg et al. 2010).  In comparing transcript-level 
expression with functional observations from the application of diazoxide and pinacidil, 
we observed the following:  (1) no significantly increased expression level of SUR1 in 
failing hearts, even though diazoxide significantly shortened APDs in the failing hearts in 
both chambers as compared to nonfailing hearts; (2) a statistically higher level of SUR2 
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expression in the ventricles of nonfailing hearts, consistent with our functional 
observation that pinacidil tends to have a greater effect on APD shortening in the 
ventricles as compared to the atria; (3) significantly higher overall expression of SUR2 
(1.08±0.37) than SUR1 (0.73±0.35, p=0.002) across all chambers, consistent with our 
observation that overall pinacidil has a greater effect on APDs than diazoxide; and (4) 
heterogeneous expression of Kir6.1 and Kir6.2 in both the LA and LV.  Since we were 
unable to obtain working antibodies for immunohistochemistry, we are unable to confirm 
these findings at the protein level. 
 
 
 
Figure 2.8:  Transcript-level expression of KATP channel subunits in the failing and 
nonfailing human heart. The asterisks (*) indicate p<0.05. 
 
 
2.4.4 Gender Dependent Atrial/Ventricular Bias 
 
 
A gender based comparison of overall relative expression levels for all targets in both 
failing and nonfailing hearts is shown in Figure 2.9.  As is evident in Figure 2.9B, there is 
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a distinct atrial gender bias, with males exhibiting overall higher expression of almost all 
genes tested in this study as compared to their female counterparts.  In the ventricles, we 
again observed a male bias of overall relative expression levels (Figure 2.9C), however 
this time the pattern emerges in nonfailing hearts, as opposed to failing hearts.  A similar 
gender comparison was completed in a study of the wild-type mouse heart and found a 
similar male gender bias in overall atrial gene expression (Iacobas, Iacobas et al. 2010).  
 
 
 
Figure 2.9: Gender dependent comparison of relative expression levels of all genes.  (A) 
Nonfailing male versus female LA.  (B) Failing male versus female LA showing a distinct 
male bias.  (C) Nonfailing male versus female LV.  (D) Failing female versus male LV.  
The dotted diagonal line represents equal expression levels between genders.  
 
2.4.5 Gender Dependent Atrial Remodeling 
 
 
Since epidemiologically males have an increased overall lifetime risk of developing atrial 
fibrillation (Kannel, Wolf et al. 1998; Wolbrette, Naccarelli et al. 2002), we focused our 
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analysis on a specific group of major ion channel transcripts known to be altered during 
the pathological electrophysiological remodeling process (Van Wagoner 2003; Gaborit, 
Steenman et al. 2005; Workman, Kane et al. 2008).  The gender dependent relative 
expression levels of these targets are shown in Figure 2.10.   
 
 
Figure 2.10: Gender dependent atrial remodeling in failing and nonfailing hearts. The 
asterisks (*) indicate p<0.05. 
  
 
Atrial fibrillation remodeling processes have revealed significant reductions in Ito (Van 
Wagoner, Pond et al. 1997), IKur (Brandt, Priebe et al. 2000), IKACh (Dobrev, Wettwer et 
al. 2002), and ICa,L (Yue, Feng et al. 1997; Van Wagoner, Pond et al. 1999).  IK1 current 
tends to be increased in AF patients (Dobrev, Wettwer et al. 2002) and INa has been 
shown to not be significantly altered (Bosch, Zeng et al. 1999).  Surprisingly, when we 
assess the gender dependence of these targets in our overall patient population, we 
observe patterns reflective of the potential propensity of our female population being 
more susceptible to the development of atrial fibrillation.  As seen in Figure 2.10, our 
female subjects (in red) exhibit significant reductions in Kv4.3, KChIP2, Kv1.5, and 
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Kir3.1, as compared with our male subjects (in blue).  We also see trends for reductions in 
Nav1.5 and Cav1.2, with no significant changes or trends regarding Kir2.1.   
 
Based on the known clinical characteristics of our patient population (Tables 2.1 and 2.2), 
we identified one failing human heart (no. 7) with a documented history of atrial 
fibrillation from which we analyzed an LA specimen.  Contrary to our expectations, as 
shown in Figure 2.11, this particular sample (shown in red) had the highest relative 
expression levels of Kv4.3, KChIP2, Kir2.1, Nav1.5, and Kv1.5 when displayed with all 
failing LA specimens of both genders.  This sample does, however, have a lower relative 
expression level of Cav1.2 than other specimens in this group. 
 
 
Figure 2.11: Relative expression levels of failing left atrial samples of both genders.  The 
red data points indicate the patient with a documented history of atrial fibrillation. 
 
We also explored the gender dependence of relative expression levels for adrenergic 
receptors as an increased level of adrenergic activity can be associated with the onset of 
atrial fibrillation (Workman 2010).  As seen in Figure 2.12, we do not observe any 
significant differences in adrenergic receptor expression in the LA of failing and 
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nonfailing hearts.  There is an apparent trend that males tend to exhibit higher overall 
relative expression levels of α1b, α1d, β1, and β2 adrenergic receptors.  This finding, 
however, may be due to an intrinsically increased sympathetic tone in men as compared 
to women (Ramaekers, Ector et al. 1998).  Interestingly, as shown in Figure 2.13, the one 
failing heart with a history of atrial fibrillation (shown in red) displays the highest relative 
expression levels of all adrenergic receptors analyzed in this study.   
 
 
Figure 2.12: Gender dependent adrenergic receptor remodeling in failing and nonfailing 
hearts.  
 
 
   
 
Figure 2.13: Relative expression levels of adrenergic receptors in failing left atrial 
samples of both genders.  The red data points indicate the patient with a documented 
history of atrial fibrillation. 
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2.4.6 Gender Dependent Ventricular Remodeling 
 
 
Since epidemiologically, females tend to have a higher incidence of long-QT syndrome 
(LQTS) and drug-induced Torsades de Pointes (Locati, Zareba et al. 1998; Abi-Gerges, 
Philp et al. 2004), we focused our analysis on a subset of ion channels known to be 
important in cardiac repolarization (Nerbonne and Kass 2005; James, Choisy et al. 2007).  
As shown in Figure 2.14, the relative expression levels of these targets reveal no 
significant differences or patterns based on gender.   
 
 
Figure 2.14: Gender dependent ventricular remodeling in failing and nonfailing human 
hearts. 
 
 
In addition, we identified five failing hearts with known histories of ventricular 
tachyarrhythmias (Table 2.2).  Their expression of these key repolarization targets in 
comparison with other failing LV samples also do not reveal any striking patterns as 
shown in Figure 2.15. 
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Figure 2.15: Relative expression levels of failing left ventricular samples of both 
genders.  The red data points indicate patients with a documented history of ventricular 
tachyarrhythmias. 
 
 
 
2.4.7 Gender Dependent Transmural Heterogeneity 
 
 
Action potential heterogeneity across the transmural ventricular wall directly alters 
electrophysiological properties during heart failure (Glukhov, Fedorov et al. 2010) and 
can be a major determinant of arrhythmias (Antzelevitch and Fish 2001).  Figure 2.16 
shows the ratios of epicardial to endocardial expression for key repolarization targets in 
both failing and nonfailing hearts of both genders.  Ratios of around one represent those 
targets, such as Kv7.1/KvLQT1, minK, Kir2.1, Kir2.2, Kir2.3, Kv4.3, and Cav1.2, that are 
uniformly expressed across the transmural wall of the LV in both failing and nonfailing 
hearts.  On the other hand, ratios of either greater or less than one represent targets that 
are more heterogeneously expressed across the LV transmural wall.  For example, 
KChIP2, the accessory protein for Ito current, exhibits a significantly larger ratio than any 
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of the other targets shown in Figure 2.16.  This heterogeneity, however, is lost in the 
failing male heart.  Kv1.4, an additional pore-forming subunit for Ito, displays a reduced 
ratio in nonfailing hearts, but again the heterogeneity is lost in the failing heart.   
 
 
Figure 2.16: Average ratios of epicardial to endocardial expression of repolarization 
targets in failing and nonfailing hearts of both genders.  The dotted black line represents 
a ratio of one.  The asterisks (*) indicate p<0.05. 
 
 
 
2.5 Discussion 
 
 
In the present study, we explored gender dependent differences in major cardiac ion 
channels, calcium handling proteins, and other transcription factors in the failing and 
nonfailing human heart.  We found significant gender-specific differences in relative 
expression levels of LA targets, such as Kv4.3, KChIP2, Kv1.5, and Kir3.1, but no clear 
gender specific differences or patterns in relative expression levels in the LV.  Analyses 
of transmural heterogeneity in the LV, however, revealed significant differences in the 
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epicardial and endocardial expression of Ito subunits and accessory proteins, such as 
Kv1.4 and KChIP2. 
 
Until recently, there has been very limited data available regarding global gender 
dependent cardiac ion channel gene expression in the human heart.  A 2010 study by 
Gaborit, et al explored gender dependent differences in the nonfailing human ventricle 
(left and right) and, unlike in our investigation, found significantly reduced expression 
levels in the female LV of key ion channels and accessory proteins important in cardiac 
repolarization (Gaborit, Varro et al. 2010).  Their patient population consisted of 10 men 
and 10 women with average ages of 38±12 years and 43±13 years, respectively.  Our 
patient population, on the other hand, consisted of both failing and nonfailing human 
hearts with significantly older average ages (failing females, 54±9 years; failing males, 
56±9 years; nonfailing females, 51±11 years; failing males, 50±18 years).  The variability 
of qPCR data has been shown to be significantly increased in aged animals (Tellez, 
Maczewski et al. 2011) and humans (Boheler, Volkova et al. 2003), which in our case 
may mask any intrinsic gender dependent expression differences in the LV in our study.   
 
The use of an older patient population may, however, be advantageous with respect to the 
gender dependent analysis of LA targets important in the generation and maintenance of 
atrial fibrillation as AF is uncommon before the age of 60 and 10% of the overall 
population develops AF by 80 years of age (Go, Hylek et al. 2001).  In addition, 1 in 4 
heart failure patients develop AF within five years of diagnosis (Wang, Larson et al. 
2003), so it is highly likely that relevant atrial remodeling processes (Nattel, Burstein et 
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al. 2008) are well underway in our patient population.  Interestingly, although overall 
men are more likely to develop heart failure (Bui, Horwich et al. 2011), women 
diagnosed with heart failure are approximately 1.5 times more likely to develop atrial 
fibrillation than their male counterparts (Benjamin, Levy et al. 1994) which may, in part, 
explain why our female population tends to display LA molecular characteristics with a 
greater potential propensity for the generation and maintenance of atrial fibrillation.  
Additionally, the overall higher atrial expression levels of almost all transcripts analyzed 
in this study, as shown in Figure 2.9B, in the failing male hearts, as compared to failing 
female hearts, may mask any intrinsic gender based differences. 
 
Interpretation of these results, however, with respect to both the LA and LV must be 
considered in light of the available clinical information, as shown in Tables 2.1 and 2.2.  
We identified one patient (failing heart no. 7) with a history of AF.  Contrary to our 
expectations with regards to atrial remodeling in AF, this patient exhibited high 
expression levels of Kv4.3, KChIP2, Kir2.1, Nav1.5, and Kv1.5 when compared with all 
other failing LA specimens of both genders, as shown in Figure 2.11.  This sample did, 
however display a relatively lower expression level of Cav1.2 as compared with other 
specimens in the group, indicative of the patient’s four month history of permanent AF 
prior to transplantation.  It should also be noted that, prior to diagnosis of AF, this patient 
had been previously diagnosed with ventricular arrhythmias which concurrently played a 
role in the progression of heart failure and overall arrhythmia history.  As previously 
reported, in human AF the primarily physiological remodeling results from changes in 
ICa,L and significant reductions of current density have only been reported after 18 months 
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of persistent AF (Brundel, Henning et al. 2002).  In addition, as shown in Figure 2.15, we 
observed no remarkable expression patterns in key repolarization targets in the LV of 
failing hearts with and without a history of ventricular tachyarrhythmias. 
   
The etiology of heart failure is thought to play an important role in the remodeling of 
specific ion channels (Koumi, Backer et al. 1995; Cerbai, Sartiani et al. 2001).  However, 
relative action potential prolongations among investigations, for example, between 
dilated and ischemic cardiomyopathy, are not always consistent (Koumi, Backer et al. 
1995; Sipido, Stankovicova et al. 1998; Verkerk, Veldkamp et al. 2000).  A recent study 
in cardiomyopathic rabbits found that the degree of hypertrophy in heart failure, as 
opposed to the general disease etiology, is the key underlying determinant of molecular 
remodeling and, consequently, action potential duration (Verkerk, Baartscheer et al. 
2011).  In particular, etiologies of heart failure with higher degrees of hypertrophy, such 
as dilated (or nonischemic) cardiomyopathy (Markus, Freitas et al. 2004), exhibit 
increased action potential prolongation as compared to other heart failure etiologies, such 
as ischemic cardiomyopathy, with lesser degrees of hypertrophy (Verkerk, Baartscheer et 
al. 2011).  In our study, we analyzed tissues from patients diagnosed with either ischemic 
or nonischemic cardiomyopathy.  Since we did not observe dramatic differences in gene 
expression between the two etiologies as shown in Figure 2.5, we assessed the left 
ventricular end diastolic dimension (LVEDD, Table 2.2) as an indicator of the degree of 
hypertrophy (Lauschke and Maisch 2009).  We did not, however, find significant 
differences in our patient population in the LVEDD (6.9±0.58 cm, ischemic 
cardiomyopathy versus 6.8±1 cm, nonischemic cardiomyopathy; p=0.74), between the 
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two heart failure etiologies.  This finding subsequently supports the lack of discernable 
overall gene expression differences between ischemic and nonischemic cardiomyopathy 
in this study. 
 
Regardless of disease etiology, prolongation of the cardiac action potential is a hallmark 
of heart failure (Tomaselli and Marban 1999).  Furthermore, heterogeneous dispersion of 
repolarization transmurally across the ventricular wall manifests as a larger-scale 
prolongation in the QT interval of the electrocardiogram.  This prolongation, which is 
also present in heritable conditions, such as long-QT and Brugada syndromes, may also 
be proarrhythmic (Antzelevitch and Fish 2001).  In our recent study, we provide direct 
functional experimental evidence of transmural, heterogeneous action potentials in the 
human LV wedge preparation (Glukhov, Fedorov et al. 2010).  In this study, as shown in 
Figure 2.16, we explored the potential molecular mechanisms of that heterogeneity.  We 
confirm that epicardial cells exhibit a prominent transient outward current (Ito) manifested 
as significant differences in KChIP2 across the transmural wall (Antzelevitch and Fish 
2001).  We are unable, however, to pinpoint other targets potentially responsible for this 
heterogeneity as other ion channels prominent in repolarization are more homogenously 
expressed across the transmural surface in our specimens.  In addition, we do not find 
transcript-level expression of connexin 43 to be heterogeneous, despite its significant 
reduction in the epicardium at the protein level in both failing and nonfailing hearts in our 
previous study (Glukhov, Fedorov et al. 2010).  Consequently, patterns of molecular 
heterogeneity directly affecting action potential durations may either be due to the 
presence of smaller “islands” of differential gene expression and function (Antzelevitch, 
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Shimizu et al. 1999; Glukhov, Fedorov et al. 2010) not captured in this study or post-
translational protein modifications (Roden and Kupershmidt 1999) not assessed in our 
transcript-level investigation.     
 
 
This study was conducted without assessing the potential contribution of sex steroid 
hormones (James, Choisy et al. 2007; Luczak and Leinwand 2009; Yang, Kurokawa et al. 
2010).  It has been shown that these hormones effect the expression of various ion 
channels though both genomic and non-genomic mechanisms and consequently alter 
cardiac conduction, repolarization, and susceptibility to arrhythmias (Furukawa and 
Kurokawa 2007).  Therefore, in assessing the gender dependency of cardiac ion channels, 
it will be important to consider the presence and effect of these hormones in the patient 
population in future studies.      
 
The wealth of information gathered from large-scale gene expression studies such as this 
and others (Chandler, Greener et al. 2009; Gaborit, Varro et al. 2010), not only provides 
insight into the gender dependent, pathological, or regional changes in ion channel 
expression, but also provides solid physiological data that can be incorporated into 
computational models.  Constructing useful models of human electromechanical activity 
requires a thorough understanding of the distribution of ion channels, calcium handling 
proteins, and other ion transporters in various regions of the heart, as well as their 
modifications due to disease and gender as we have investigated in this study of the 
human heart. 
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2.6 Conclusion 
 
 
Epidemiologically, it is clear there is a gender disparity in arrhythmia incidence.  To 
attempt to elucidate the underlying molecular mechanisms of these differences, we have 
explored the gender dependent expression of various ion channels, calcium handling 
proteins, and other transcription factors in the failing and nonfailing human heart in this 
study.  While we observed significant gender dependent differences in atrial tissues, we 
did not however observe clear patterns of gender dependent expression in the ventricles.  
Our data do, however, emphasize the importance of addressing such confounding factors 
as gender, age, and disease progression when exploring ionic remodeling processes in the 
human heart.     
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3 Virtual Histology of the Human Heart Using 
Optical Coherence Tomography 
 
 
 
3.1 Abstract 
 
 
Optical coherence tomography (OCT) allows for the visualization of micron-scale 
structures within nontransparent biological tissues.  For the first time, we demonstrate the 
use of OCT in identifying components of the cardiac conduction system and other 
structures in the explanted human heart.  Reconstructions of cardiac structures up to 2 
mm below the tissue surface were achieved and validated with Masson Trichrome 
histology in atrial, ventricular, sinoatrial nodal, and atrioventricular nodal preparations.  
The high spatial resolution of OCT provides visualization of cardiac fibers within the 
myocardium, as well as elements of the cardiac conduction system; however, a limiting 
factor remains its depth penetration, demonstrated to be ~2mm in cardiac tissues.  
Despite its currently limited imaging depth, the use of OCT to identify the structural 
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determinants of both normal and abnormal function in the intact human heart is critical in 
its development as a potential aid to intracardiac arrhythmia diagnosis and therapy. 
 
 
3.2 Introduction 
 
 
In the 17 years since its initial introduction (Huang, Swanson et al. 1991), optical 
coherence tomography (OCT) has gained prominence as a diagnostic imaging modality 
in the fields of ophthalmology (Costa, Skaf et al. 2006; Chang and Budenz 2008; Drexler 
and Fujimoto 2008), vascular cardiology (Pinto and Waksman 2006; Tearney, Jang et al. 
2006; Brezinski 2007; Guagliumi and Sirbu 2008), and dermatology (Welzel 2001; 
Gambichler, Moussa et al. 2005).  Major clinical applications of cardiac OCT currently 
focus on the visualization of the coronary vasculature – for example, identifying unstable 
plaques and guiding interventional techniques such as stent placement (Brezinski 2007).  
However, within the realms of cardiac research, the applications of OCT have been 
steadily increasing.  Recently, OCT has been used to study developing murine and avian 
hearts (Luo, Marks et al. 2006; Jenkins, Chughtai et al. 2007), as well as the 
morphogenesis and myocardial strains of the embryonic chick heart (Filas, Efimov et al. 
2007).  Additional studies have shown the utility of OCT in recognizing the components 
of the cardiac conduction system of the rabbit, specifically the atrioventricular (AV) node 
(Gupta, Rollins et al. 2002)  and the Purkinje network (Jenkins, Wade et al. 2005).  Our 
recent study extended these findings by exploring the relationship in the rabbit heart 
between function, visualized through optical mapping, and structure, imaged through 
OCT (Hucker, Ripplinger et al. 2008).  Concurrently, tools are also under development to 
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analyze OCT data, including 3-D cardiac fiber structure (Fleming, Ripplinger et al. 
2008).  In this study, we aimed to explore the utility of OCT in identifying components of 
the conduction system and other structures in the explanted human heart. 
 
Clinical cardiac anatomical visualization and reconstruction techniques, including 
magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, have a 
variety of diagnostic capabilities, including localization of arterial plaques, evaluation of 
bypass grafts and stents, and quantification of wall properties.  Although these modalities 
provide better depth of penetration than OCT, they deliver relatively low resolution 
images.  In biological specimens, OCT, on the other hand, boasts spatial image 
resolutions ranging from submicrometer though 15 µm, which can be 10 to 100 times 
greater than other modalities and comparable to conventional histological analyses 
(Povazay, Bizheva et al. 2002; Fujimoto 2003). 
 
In addition to its high spatial resolution, OCT also has other advantages pertaining to 
diagnostics and surgical guidance.  First, OCT can be performed in real time and in situ, 
allowing for convenient online guidance and evaluation of treatment.  Second, OCT 
technology can be miniaturized into a catheter-based imaging system (Tearney, Brezinski 
et al. 1996; Tearney, Brezinski et al. 1997) and threaded through the vasculature into the 
cardiac chambers.  Last, OCT can be used for Doppler blood flow and the quantification 
of blood oxygenation (Chen, Milner et al. 1997; Rollins, Yazdanfar et al. 2002).   
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Despite its high spatial resolution, OCT is limited by its depth penetration, estimated to 
be 2 to 3 mm in nontransparent biological tissues (Fujimoto 2003).  Although there are 
techniques in development to enhance both its depth penetration and resolution (Schenk 
and Brezinski 2002; Fujimoto 2003; Huang, Liu et al. 2008), currently standard OCT 
does not achieve the typical depths of MRI, CT, and ultrasound, which can acquire 
images of internal structures noninvasively.  The advantage of OCT, however, lies in its 
superior spatial resolution, which enables the visualization of complex fiber architecture, 
as explored in this study of the human heart.  
 
 
3.3 Materials and Methods 
 
 
3.3.1 Experimental Preparations 
 
 
The use of human hearts for research was approved by the Institutional Review Boards at 
both Washington University and the University of Minnesota. 
 
Explanted failing human hearts (n=12) were obtained at the time of cardiac 
transplantation (Barnes-Jewish Hospital, St. Louis, Missouri) and immediately perfused 
with cardioplegic solution (4°C).  Tissue preparations from the right atria (RA), left 
ventricle (LV), infarcted right ventricle (RV), and atrioventricular junction (AVJ) were 
isolated from the rest of the heart.  An additional sinoatrial nodal (SAN) specimen was 
obtained through the Upper Midwest Organ Procurement Organization (Life Source, St. 
Paul, Minnesota) and the University of Minnesota and shipped frozen to St. Louis.  The 
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tissues were perfused and fixed with 3.7% formaldehyde overnight and then transferred 
to 20% sucrose for 2 days.  The tissues were photographed and clearly marked with pins 
to precisely correlate the OCT images with histology.  OCT was performed 3 to 4 days 
later.  Table 3.1 shows the clinical data regarding each specimen. 
 
 
 
Figure 3.1: Clinical data.  Relevant clinical information regarding each specimen.  The 
mean age of the patients was 50±10 years. 
 
 
 
3.3.2 OCT Imaging 
 
 
OCT, based on the principle of low-coherence interferometry, measures the backscatter 
of light.  The coherence of the backscattered light from the sample arm (or tissue) and 
reference arm result in the generation of multiple A-scans (axial scans), which are then 
converted to pixel intensity and combined to form a tomogram (B-scan), or slice of tissue 
(Brezinski 2006), as described in Section 1.5.2.2 and shown in Figure 1.6.  The basics of 
our OCT system have been described previously (Hu and Rollins 2005; Hucker, 
Ripplinger et al. 2008).  We imaged all cardiac tissues in 1x1, 2x2, or 4.5x4.5 mm 
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overlapping segments from the epicardial, endocardial, or transmural surfaces, with final 
axial and lateral resolutions of 10 µm (in air).  
 
 
3.3.3 Histology 
 
 
After imaging, the tissue specimens were embedded and frozen in Tissue-Tek OCT 
compound (Electron Microscopy Sciences, Hatfield, Pennsylvania) and stored at -80°C.  
The tissues were then cryosectioned at 16 µm and mounted on Superfrost Plus glass 
slides (Fisher Scientific).  Sections were then stained using Masson Trichrome (IMEB, 
San Marcos, California), imaged on a Nikon C1/80i confocal microscope with an 
attached AxioCam MRc5 brightfield camera (Carl Zeiss), and visually compared with the 
corresponding OCT images. 
 
 
3.3.4 Computational Analysis and Statistics 
 
 
Images were processed using MATLAB (Mathworks) and Volocity (Improvision).  
Initially, each 2-D slice was acquired six times, and the six frames were then averaged 
together to reduce background noise.  Subsequently, during post acquisition data analysis, 
median filtering was performed with a 3x3 smoothing kernel to further reduce speckle 
noise (Tearney, Yabushita et al. 2003).  Three-dimensional (3-D) tissue reconstructions 
were created using both Volocity and custom-written MATLAB programs.  Additional 
analysis programs were developed in MATLAB for optical tissue slicing, to determine 
fiber orientation in relation to the tissue surface (Hucker, Ripplinger et al. 2008), and for 
determination of the depth of OCT penetration.  Depth penetration of each 4.5x4.5 mm 
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field of view acquired across all tissue preparations was assessed via a global 
thresholding approach (Brezinski 2006).  Quantitative data are expressed as mean ± 
standard deviation.  A Student’s t-test was used to determine statistical significance.  A p 
value of <0.05 was considered statistically significant. 
 
 
3.4 Results 
 
 
3.4.1 OCT of the Atria and Ventricles 
 
 
Atrial (n=6) and ventricular (n=8) preparations were imaged from both the endocardial 
and epicardial surfaces.  Atrial depth penetration (0.94±0.14 mm) significantly differed 
(p=1.74x10-8) from that of the ventricles (1.29±0.46 mm). 
 
In atrial tissues, we created 3-D reconstructions of the trabeculations and distinguished 
fiber structures up to 1 mm below the endocardial surface (Figure 3.1).  In the ventricle, 
we were able to distinguish changes in fiber orientation in areas located within 4.5 mm of 
each other and 0.4 mm below the epicardial tissue surface (Figure 3.2a-c).  Although our 
current means of imaging does not achieve the depth required to reconstruct fiber 
architecture throughout the entire thickness of the human myocardium, we do have 
evidence that this can be accomplished in animal models, in which our current OCT 
system is able to penetrate through a larger percentage of the myocardium (Hucker, 
Ripplinger et al. 2008).   
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Figure 3.1: OCT of the Atria.  (a) Atrial trabeculations of the RA appendage as viewed 
from the endocardium. (b) 3-D OCT rendering of the trabeculations.  (c) Fiber 
architecture located 0.44 mm below the surface. 
 
 
Epicardial OCT can also afford us a view of the coronary vessels.  Figure 3.2d shows a 
histological cross section through an intact coronary vein, with the corresponding OCT 
cross section shown in Figure 3.2e.  Figure 3.3 shows the resultant 2-D and 3-D OCT 
images from a coronary artery, isolated from the RV epicardial surface, with a main 
branch diameter of 2 mm.  In particular, note that in Figure 3.3c, we are able to 
distinguish arterial branches less than 1 mm in diameter, as indicated by the red 
arrowhead. 
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Figure 3.2: OCT of the Ventricles.  (a) Photograph of an LV preparation as viewed from 
the epicardium.  (b) Fiber architecture in the area indicated by the red box, 0.4 mm 
below the epicardial surface.  (c) Fiber architecture 0.4 mm below the epicardial surface 
located 4.5 mm to the right of (b) as indicated by the blue box.  The average angle of the 
fibers shifted by 30°.  (d) Histological cross section of the LV, affording a view of a 
coronary vein.  (e) 2-D OCT image corresponding to (d). 
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Figure 3.3: OCT of an isolated coronary artery.  (a) Photograph of an isolated coronary 
artery.  (b) 2-D cross section of the artery.  (c) 3-D OCT rendering of the artery.  The red 
arrowhead indicates an arterial branch less than 1 mm in diameter. 
 
In addition, we imaged RV infarcts (n=3) from the epicardial, endocardial, and 
transmural surfaces.  Although we were able to detect significant (p=3.16x10-7) changes 
in depth penetration as compared with adjacent noninfarcted ventricles, as measured from 
the epicardium and endocardium, we could not visually identify the fibroses from these 
surfaces with our OCT system.  In contrast, when we imaged from the dissected 
transmural surface, as shown in Figure 3.4, the fibrotic tissue of the infarct is clearly 
visible using OCT and correlates well with histology. 
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Figure 3.4: Transmural OCT of the infarcted right ventricle.  (a) Histology of an 
epicardial RV infarct and its underlying tissue.  (b) Corresponding OCT cross section of 
the infarct.  The dotted line represents the approximate border between the infarct and 
viable myocardium. 
 
 
3.4.2 OCT of the Sinoatrial Node 
 
 
OCT of the SAN was initially attempted from the endocardial surface, the primary point 
of access during intracardiac procedures.  The SAN specimen was dissected to include 
the RA appendage, crista terminalis (CT), and approximately 2 cm of atrium beyond the 
CT (Figure 3.5a).  The specimen was then imaged in overlapping 4.5x4.5 mm segments, 
beginning along the CT and extending to the border of dissection.  Figure 3.5b shows 3-D 
reconstructions of the tissue recreated from scans along the CT/RA border, as indicated 
by the dashed line in Figure 3.5a.  Compared with the 2-D tomogram in Figure 3.5c, 
Figure 3.5d exhibits an increased number of tissue layers as the transitional area closer to 
59 
the SAN is approached.  As the OCT field of view begins to incorporate the tissue layers 
above the SAN (Figure 3.5e,f), it is readily apparent that the primary pacemaker of the 
heart, defined as a subepicardial structure (Ho, Anderson et al. 2002), is located too deep 
within the myocardium (at 1.75 mm) for imaging from the endocardial surface.  The 
average depth penetration for this specimen from the endocardial surface was 1.06±0.21 
mm.  Imaging from the epicardial surface was hindered by a layer of fat along the sulcus 
terminalis.  Although fat intrinsically has a lower backscattered reflectance than normal 
cardiac tissue (Brezinski, Tearney et al. 1996), the loss in depth penetration was such that 
we could not visualize the SAN.  In addition, the thin layer of epicardial fibrous tissue, 
indicated by the arrow in Figure 3.6a, may contribute to the loss of depth when the SAN 
is imaged from the epicardium. 
 
 
Figure 3.5: Endocardial OCT of the sinoatrial node.  (a) Dissected SAN preparation.  (b) 
3-D reconstruction of the tissue area as indicated by the red box.  (c,d) 2-D tomograms 
from (b) as indicated by the green and purple lines.  (e) Histology with the SAN indicated 
by the solid line in the lower-right corner.  (f) OCT cross section corresponding to (e) 
showing a strong relationship between the transitional area as defined histologically and 
via OCT; however the SAN is unable to be imaged endocardially using this method.  
Abbreviations – RAA: RA appendage; SVC: superior vena cava; IVC: inferior vena cava; 
CT: crista terminalis; IAS: interatrial septum; SAN: sinoatrial node. 
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We also imaged the SAN specimen transmurally (i.e., in dissected tissue), which allowed 
us to consistently locate the SAN throughout its entire length and its proximity to the 
SAN artery.  In this way, we were also able to compare the OCT image to a sister 
histology section.  Due to the prominence of fibroblasts and connective tissue, which 
serve to isolate the SAN myocytes from the surrounding atrial tissue (Boyett, Honjo et al. 
2000), the SAN is readily identifiable as a unique structure with transmural OCT (Figure 
3.6), without the need for histological staining. 
 
 
 
Figure 3.6: Transmural OCT of the sinoatrial node.  (a) Histological section of the SAN 
and surrounding tissues.  (b) Transmural OCT of the same area.  The asterisk (*) 
identifies the SAN, and the black arrow in (a) points to a thin layer of epicardial fibrous 
tissue that may have prevented OCT imaging of the SAN from the epicardium.  
Abbreviations – CT: crista terminalis; SAN: sinoatrial node. 
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3.4.3 OCT of the Atrioventricular Junction 
 
 
OCT of the AVJ was achieved endocardially in five of nine preparations (56%).  In the 
five preparations whose AVJ was imaged, those junctional elements, including the His 
bundle and AVN, were located within 2 mm of the endocardial surface.  As the average 
depth penetration in this region across all specimens was 0.96±0.25 mm, those elements 
located deeper than 2 mm, as confirmed via histology, were unable to be identified in this 
manner. 
 
All AVJ specimens were dissected for imaging of the entire Triangle of Koch, including 
a 1 to 2 cm border incorporating additional atrial and ventricular tissues (Figure 3.7a).  
The specimens were then optically mapped in overlapping 4.5x4.5 mm segments, with 
higher magnification images acquired in regions of interest, particularly the His bundle 
and AVN.  In Figure 3.7, 3-D reconstructions revealed discrete structures located 
approximately 1 mm below the tissue surface (Figure 3.7b), corresponding to the 
locations of the His bundle and AVN as identified with traditional histology.  In addition, 
2-D tomograms showed this discrete structure encased in fibrous tissue, which manifests 
as a black envelope surrounding the brighter tissue of the bundle itself (Figure 3.7c,d).  
As our field of view progresses proximal to the His bundle, approaching the rightward 
extension (RE), also known as the inferior nodal extension (INE), we have a clear view 
of the AVN/RE (Figure 3.7e,f).  The clarity is such that we can resolve the blood vessels 
(ranging from 320 to 750 µm in diameter) located within the AVN itself.  The location of 
the blood vessels are confirmed with both histology and OCT. 
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Figure 3.7: Endocardial OCT of the atrioventricular junction.  (a) Dissected AVJ 
preparation.  (b) 3-D reconstruction of the tissue area as indicated by the red box.  (c,d) 
2-D tomograms from (b) as indicated by the purple and yellow lines.  (e) Histology of the 
AVN as indicated by the green line in (a).  (f) Corresponding 2-D OCT image of (e) 
showing a strong relationship between the AV node as defined histologically and via 
OCT.  Red arrowheads indicate blood vessels within the node, visible with both histology 
and OCT.  Abbreviations- IAS: interatrial septum; TT: tendon of Todaro; CS: coronary 
sinus; LE: leftward extension; CN: compact node; LNB: lower nodal bundle; CFB: 
central fibrous body; RE: rightward extension; INE: inferior nodal extension; VS: 
ventricular septum; TV: tricuspid valve; AVN: atrioventricular node. 
 
 
3.5 Discussion 
 
 
Since its inception, OCT has undergone technical advances, including, but not limited to, 
the establishment of ultrahigh-resolution OCT (Drexler, Morgner et al. 1999; Drexler 
2004), spectral/Fourier domain OCT (Fercher, Hitzenberger et al. 1995; Wojtkowski, 
Leitgeb et al. 2002; Yun, Tearney et al. 2003; Nassif, Cense et al. 2004; Oh, Yun et al. 
2008), numerous improvements in light sources (Bouma, Tearney et al. 1995; Bouma, 
Tearney et al. 1996; Unterhuber, Povazay et al. 2004), development of a catheter-based 
imaging probe (Tearney, Brezinski et al. 1996; Tearney, Brezinski et al. 1997), and 
ultrasound-enhanced OCT, delivering greater spatial resolution and depth penetration 
(Schenk and Brezinski 2002; Huang, Liu et al. 2008).  However, as OCT technology 
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continues to advance, there still exist technical challenges that remain to be addressed, 
such as the removal of blood from the imaging field to avoid substantial signal 
attenuation due to a refractive index mismatch between the cytoplasm of red blood cells 
(RBCs) and blood plasma.  Current intravascular OCT systems incorporate a balloon 
catheter occlusion system (Guagliumi and Sirbu 2008); however, this technique cannot be 
easily applied to imaging the intact heart.  In addition, Dextran, a biocompatible agent, 
has been shown to substantially improve the resolution and depth of OCT imaging 
through blood by increasing the refractive index of plasma to a value near that of the 
RBC cytoplasm (Brezinski, Saunders et al. 2001; Xu, Yu et al. 2008).  This technique, 
known as index matching, has been shown to significantly diminish signal attenuation; 
however, additional in vivo testing is necessary. 
 
The use of OCT to image the cardiac conduction system and other structures in the 
explanted human heart has many potential applications in cardiology.  For example, 
cardiac fibers in the trabeculated endocardial structures of the atria and ventricles, as well 
as surviving fibers in the infarct border zone, often may contribute to the propensity to 
develop reentrant arrhythmias (Valderrabano, Lee et al. 2001; Valderrabano 2007).  Our 
data indicates that OCT may prove of value in identifying these structures (Figures 3.1, 
3.2, and 3.4), and thus potentially arrhythmic areas of the heart. 
 
Although OCT catheters, with diameters as small as 0.3 mm, are commercially available 
for intravascular imaging of vulnerable plaques (Guagliumi and Sirbu 2008), the size of 
the target artery and/or tortuosity of the approach may preclude imaging in this manner.  
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In a recent review of the clinical use of intravascular OCT, Guagliumi and Sirbu state that 
cardiac vessels suitable for intravascular OCT are between 2.5 and 3.75 mm in diameter 
and have tortuosity angles less than 90 degrees (Guagliumi and Sirbu 2008).  However, 
for vessels not exhibiting these characteristics, epicardial imaging may be a viable 
alternative to intravascular imaging (Figures 3.2 and 3.3). 
 
We have also demonstrated OCT imaging of the conduction system, specifically the SAN 
and AVJ.  These components are vital in the normal function of the heart; therefore, the 
ability to target them with a high-resolution imaging modality, such as OCT, has any 
number of potential applications.  As the precise location of both the SAN and AVJ 
within the atrial myocardium is difficult to pinpoint with currently used imaging 
modalities, their structure can be uniquely identified due to the varying absorption 
properties present both in the nodal structures, which contain a prominence of fibroblasts 
and connective tissue, and in the surrounding tissues, as is shown in Figures 3.5-3.7, 
using OCT. 
 
 
3.6 Conclusion 
 
 
Although traditional cardiac imaging modalities, including MRI, CT, and ultrasound, 
continue to provide physicians with vital information in the diagnosis of cardiac 
conditions, we have shown the potential of OCT in providing high-resolution, in situ 
images of the cardiac conduction system and other structures in the intact, explanted 
human heart.  However, despite its ability to distinguish cardiac microstructures as shown 
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in this study, the technique is currently hampered by its depth penetration in cardiac 
tissues.  Based on the presented data, we conclude that OCT is emerging as an important 
imaging modality with the potential to facilitate and guide electrophysiology studies, 
ablation therapy, implantation of pacing leads, and future cell and tissue engineering 
therapies subsequent to additional development. 
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4 Quantification of Fiber Orientation in the Canine 
Atrial Pacemaker Complex Using Optical 
Coherence Tomography 
 
 
 
4.1 Abstract 
 
 
The atrial pacemaker complex is responsible for the initiation and early propagation of 
cardiac impulses.  It can also participate in such arrhythmias as atrial fibrillation and 
flutter.  Optical coherence tomography (OCT), a nondestructive imaging modality, with 
spatial resolutions ~1-15 µm can be used to identify unique fiber orientation patterns in 
this region of the heart.  In this study, functionally characterized canine sinoatrial nodes 
(SAN, n=7) were imaged using OCT up to ~1 mm below the endocardial tissue surface.  
OCT images were directly compared to their corresponding histological sections.  Fiber 
orientation patterns unique to the crista terminalis (CT), SAN, and surrounding atrial 
myocardium were identified with dominant average fiber angles of 89±12°, 110±16°, and 
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95±35°, respectively.  Both the CT and surrounding atrial myocardium displayed 
predominantly unidirectional fiber orientation patterns within each specimen, whereas the 
SAN displayed an increased amount of fiber disarray manifested quantitatively as a 
significantly greater standard deviation in fiber angle distribution within specimens 
(33±7° versus 23±5°, atrium (p=0.02); 18±3°, CT (p=0.0003)).  We also identified 
unique, local patterns of fiber orientation specific to the functionally characterized block 
zone.  In addition, we demonstrate the ability of OCT to detect components of the atrial 
pacemaker complex, which are involved in both normal and abnormal cardiac 
conduction.  
 
 
4.2 Introduction 
 
 
The sinoatrial node (SAN) is a complex, heterogeneous structure located in the upper, 
posterior region of the right atrium (RA) responsible for initiating cardiac impulses 
during normal conduction.  Structural investigations of the SAN have revealed it to be a 
diffuse, cigar-shaped structure extending between the superior and inferior vena cavae 
(Dobrzynski, Li et al. 2005), and electrically isolated from the remaining bulk of atrial 
tissue (Sanchez-Quintana, Cabrera et al. 2005; Boyett, Inada et al. 2006; Oren and Clancy 
2010).  The location of the leading pacemaker within the larger SAN is highly variable 
and can be affected by both vagal tone and changes in extracellular ion concentrations 
(Fedorov, Hucker et al. 2006; Monfredi, Dobrzynski et al. 2010).  Early experiments 
investigating the mechanism of impulse formation and propagation through the SAN 
have pointed to the presence of discrete exit pathways (Bromberg, Hand et al. 1995; 
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Schuessler 2003), which have more recently been functionally and anatomically 
identified in both the canine and human SAN (Fedorov, Schuessler et al. 2009; Fedorov, 
Glukhov et al. 2010). 
 
Atrial arrhythmias, such as flutter and fibrillation, have been shown to involve both the 
SAN and its exit pathways (Fedorov, Chang et al. 2010).  These arrhythmias can be 
diagnosed during routine electrophysiology studies and potentially eradicated by catheter 
ablation procedures.  Successful procedural outcomes oftentimes depend on the precise in 
situ identification of the atrial pacemaker complex, as well as normal/abnormal atrial 
myocardium.  Current clinical anatomical visualization techniques, including magnetic 
resonance imaging (MRI), computed tomography (CT), and ultrasound, deliver relatively 
low spatial resolutions and cannot be performed in real time during electrophysiology 
procedures.  Optical coherence tomography (OCT), on the other hand, is an imaging 
technique allowing for the visualization of micron-scale structures within nontransparent 
biological tissues, with resolutions ranging from submicrometer through 15 µm (Povazay, 
Bizheva et al. 2002; Fujimoto 2003).  
 
The use of OCT in visualizing components of the human heart vital to both normal and 
abnormal conduction, including high-resolution identification of the SAN, was evaluated 
in our recent study as described in Chapter 3 of this dissertation.  Additional previous 
studies have shown the utility of OCT in imaging components of the conduction system 
in both rabbit (Gupta, Rollins et al. 2002; Jenkins, Wade et al. 2005) and human hearts as 
described in Chapter 3.  We have also explored the relationship between structure, 
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imaged using OCT, and function, visualized using optical mapping, in the rabbit SAN 
(Hucker, Ripplinger et al. 2008).  The rabbit SAN, however, is essentially a two-
dimensional structure (Bleeker, Mackaay et al. 1980), as opposed to the three-
dimensional canine (Bromberg, Hand et al. 1995; Fedorov, Schuessler et al. 2009) and 
human (Boineau, Canavan et al. 1988; Fedorov, Glukhov et al. 2010) SANs.  In this 
study, we aimed to apply ex vivo OCT imaging to canine SANs, which have been 
functionally characterized using optical mapping as published in our previous study 
(Fedorov, Schuessler et al. 2009).  Furthermore, we aimed to structurally identify 
elements of the atrial pacemaker complex, including nodal tissue and exit pathways, in 
addition to quantifying local fiber orientation in these areas important in the generation 
and maintenance of both normal and abnormal cardiac conduction. 
 
 
4.3 Materials and Methods 
 
 
4.3.1 Experimental Preparation 
 
 
The experimental protocol was approved by the Institutional Animal Care and Use 
Committee of Washington University.   
 
Canine right atrial preparations (n=7) were initially isolated and functionally-
characterized using optical mapping with a voltage-sensitive dye, as described in our 
previous study (Fedorov, Schuessler et al. 2009).  Immediately after the optical mapping 
experiment, the tissue preparations were perfused and fixed with 3.7% formaldehyde 
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overnight and then transferred to 20% sucrose for two days.  Specimens were dissected to 
include the right atrial appendage (RAA), crista terminalis (CT), and 2-3 cm of tissue 
beyond the CT where the SAN is located (James 1962; Monfredi, Dobrzynski et al. 
2010).  The tissues were then photographed and clearly marked with pins to correlate 
OCT images with corresponding structural and functional data sets. 
 
 
4.3.2 OCT Imaging 
 
 
The basics of our OCT system have been described previously (Hu and Rollins 2005; 
Hucker, Ripplinger et al. 2008).  In short, we imaged each specimen in overlapping 
segments from the endocardial surface, with final axial and lateral resolutions of 10 µm 
(in air). 
 
 
4.3.3 Histology and Immunohistochemistry 
 
 
After imaging, tissue specimens (n=5) were embedded and frozen in Tissue-Tek OCT 
compound (Electron Microscopy Sciences, Hatfield, Pennsylvania) and stored at -80°C.  
The tissues were then cryosectioned at 16 µm (n=4, parallel to endocardium; n=1, 
perpendicular to endocardium) and mounted on Superfrost Plus glass slides (Fisher 
Scientific).  Sister sections were then stained using either Masson Trichrome (IMEB, San 
Marcos, California) or antibodies for the gap junctional protein- connexin 43 (Sigma-
Aldrich, St. Louis, Missouri), the cardiac myocyte marker- α-actinin (Sigma-Aldrich, St. 
Louis, Missouri), and the fibroblast marker- vimentin (Progen Biotechnik, Heidelberg, 
Germany), as described previously (Hucker, McCain et al. 2008; Fedorov, Schuessler et 
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al. 2009).  Imaging of both histology and immunohistochemistry was performed on a 
Nikon C1/80i confocal microscope with an attached AxioCam MRc5 brightfield camera 
(Carl Zeiss). 
 
 
4.3.4 OCT Image Processing and Analysis 
 
 
OCT images were processed using MATLAB (Mathworks), as described previously in 
Chapter 3.  Individual OCT images were acquired six times, and then averaged to reduce 
background noise.  Median filtering was also performed with a 3x3 smoothing kernel to 
further diminish speckle noise (Tearney, Yabushita et al. 2003).  Custom-designed 
analysis programs were developed in MATLAB for virtual tissue slicing in order to 
visualize fiber orientation in relation to the tissue surface (Hucker, Ripplinger et al. 
2008), as well as to quantify the depth of OCT imaging as described in Chapter 3.  
Quantification of 2-D fiber orientation was performed using an automated gradient based 
algorithm developed and validated in cardiac tissue (Fleming, Ripplinger et al. 2008).  
Areas of interest from which fiber orientation was assessed included the CT, atrial 
myocardium, SAN, block zone, and exit pathway(s).  These areas were identified using a 
combination of histology, immunohistochemistry, and functional data sets. 
 
Quantitative data are expressed as mean ± standard deviation.  A Student’s t-test was 
used to determine statistical significance.  A p-value of <0.05 was considered statistically 
significant.    
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4.4 Results 
 
 
4.4.1 Identification of the Atrial Pacemaker Complex 
 
 
OCT imaging of the canine atrial pacemaker complex achieved an average depth 
penetration of 1.28±0.23 mm from the endocardial surface across all specimens.  The 
approximate thickness of tissue incorporating and surrounding the atrial pacemaker 
complex was 2-3 mm.  Although the SAN is defined as a primarily subepicardial 
structure (Sanchez-Quintana, Cabrera et al. 2005), inferior portions of the node are 
located closer to the endocardial surface bringing them within range for OCT (Fedorov, 
Glukhov et al. 2010).  Consequently, although OCT could not consistently image 
throughout the entire thickness of tissue in the area of the SAN, the depth penetration was 
such that key components of the atrial pacemaker complex could be visualized.  OCT 
failed, however, at identifying nodal tissue in one heart out of seven total imaged. 
 
The initial functional and structural identification of the atrial pacemaker complex was 
achieved through the merging of several data sets, as shown in Figure 4.1.  The primary 
field of view for all imaging modalities encompassed tissue ranging from the crista 
terminalis (CT) to the interatrial septum (IAS) (Figure 4.1A), which incorporated both 
nodal tissue and normal atrial myocardium into each data set.  Optical mapping revealed 
the location of the primary pacemaker (Figure 4.1B), the block zone, and two (or more) 
exit pathways from the SAN (Fedorov, Schuessler et al. 2009).  In addition, both 
histology (Figure 4.1C) and immunofluorescent labeling for connexin 43 (Figure 4.1D) 
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pinpointed the location of the SAN, as distinguished from surrounding normal atrial 
myocardium. 
 
Resolution-wise OCT is comparable to conventional histological analyses (Povazay, 
Bizheva et al. 2002; Fujimoto 2003), which allows for the direct comparison of both 
techniques in identifying structures within the myocardium.  Figure 4.2 illustrates this 
concept from two overlying fields of view.  The images shown in Figure 4.2A-B are 
located approximately 0.44 mm below the endocardial surface, whereas those images 
shown in Figure 4.2C-D are located at a depth of approximately 0.69 mm.  Major 
identifying structures, such as the sinus node artery and a pinhole (as indicated by the red 
arrowheads), are apparent using both conventional and virtual histology.  In addition, 
abrupt changes in fiber orientation and organization can be identified and confirmed with 
OCT, as indicated by the arrows in Figure 4.2. 
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Figure 4.1: Identification of the atrial pacemaker complex.  (A) Photograph of a typical 
SA nodal preparation as viewed from the endocardium with relevant structures labeled.  
(B) Typical activation map of normal sinus rhythm from the same field of view as in panel 
A.  The white ellipsoid represents the area of earliest activation within the node.  (C) 
Typical histology slide of the SAN with its approximate borders outlined by the dotted 
black line.  (D) Typical immunofluorescent slide of the SAN with its approximate border 
outlined by the dotted white line.  Connexin 43 is absent within the borders of the SAN.  
Abbreviations – SAN: sinoatrial node; SVC: superior vena cava; IVC: inferior vena 
cava; RAA: right atrial appendage; IAS: interatrial septum; Cx43: connexin 43. 
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Figure 4.2: Correlation of histology and OCT.  Corresponding histology and OCT slices 
taken from approximately 0.44 mm (A,B) and 0.69 mm (C,D) below the endocardial 
surface.  Red arrowheads indicate pinholes used as reference points and arrows indicate 
abrupt changes in fiber orientation. 
 
 
4.4.2 Quantification of Fiber Orientation 
 
 
Fiber orientation, as related to impulse propagation in the atrial pacemaker complex, was 
assessed from three fields of view in each heart.  Figure 4.3 shows typical fiber 
orientation patterns from areas identified as the crista terminalis, as indicated by the green 
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boxes in Figure 4.3B-C, and the interatrial septum, as indicated by the blue boxes in 
Figure 3D-E, at two depths (0.17 and 0.49 mm) below the endocardial tissue surface.  As 
is evident in the OCT images, these areas of tissue exhibit strong unidirectional fiber 
orientation with dominant fiber angles of 70±20° and 137±16° as measured in the crista 
terminalis and interatrial septum, respectively. 
 
 
Figure 4.3: Identification of the crista terminalis and interatrial septum with OCT.  (A) 
Photograph of an SA nodal preparation as viewed from the endocardium with the OCT 
fields of view for the CT and IAS identified by the green and blue boxes, respectively.  
OCT images of the unidirectional fiber orientation of the CT and IAS 0.17 mm (B,D) and 
0.49 mm (C,E) below the endocardium.  Abbreviations – SVC: superior vena cava; IVC: 
inferior vena cava; RAA: right atrial appendage; CT: crista terminalis; IAS: interatrial 
septum. 
 
OCT fields of view encompassing nodal tissue, on the other hand, exhibit very different 
orientation patterns as shown in Figure 4.4.  Initially, immediately under the endocardial 
tissue surface (Figure 4.4B, depth = 0.17 mm), there is a tendency for a strong 
unidirectional fiber orientation with a dominant angle of 130±14°, similar to the 
interatrial septum.  As the field of view progresses from the endocardium towards the 
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epicardium and through nodal tissue, the cardiac fibers display an increased amount of 
disarray, as shown in Figure 4.4E-G.  This fiber disarray is representative of SA nodal 
tissue, which propagates impulses at slower conduction velocities than normal atrial 
myocardium (Boyett, Inada et al. 2006; Fedorov, Schuessler et al. 2009).   
 
 
Figure 4.4: Identification of the sinoatrial node with OCT.  (A) Photograph of an SA 
nodal preparation as viewed from the endocardium with the OCT field of view for the 
SAN identified by the white box.  OCT images of the fiber orientation are shown at (B) 
0.17 mm, (C) 0.24 mm, (D) 0.3 mm, (E) 0.36 mm, (F) 0.42 mm, and (G) 0.49 mm below 
the endocardium. 
 
Specific fiber angle analyses, as shown in Figure 4.5, illustrate the changing orientation 
and fiber angle distributions in the CT, endocardial atrial layer above the SAN, and the 
SAN itself.  Both the CT and endocardial atrial tissue layers exhibit strong unidirectional 
fiber orientations with dominant angles centered around 69° and 130° as shown in Figure 
4.5A-F.  Nodal tissue, as verified with standard histology and immunohistochemistry, 
exhibits a higher degree of fiber disarray as reflected in a wider range of fiber angles 
(112±34°), as shown in Figure 5G-I.  All fiber orientation distributions in this specimen 
are significantly different from each other (p<0.0001). 
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Figure 4.5: Fiber angle distribution in the crista terminalis, atrium, and sinoatrial node.  
(A) OCT image of cardiac fibers in the CT.  (B) Distribution of fiber angles in the CT 
with an average dominant angle of 69±19°.  (D) OCT image of cardiac fibers in normal 
atrial myocardium located endocardial to the SAN.  (E) Assigned fiber angle vectors in 
normal atrial myocardium.  (F) Distribution of fiber angles in the atrium with an average 
dominant angle of 130±14°.  (G) OCT image of cardiac fibers in the SAN.  (H) Assigned 
fiber angle vectors in the SAN.  (I) Distribution of fiber angles in the SAN with an 
average dominant angle of 112±34°. 
 
Overall fiber angle orientation, as summarized in Figure 4.6, was consistent across 
samples within the CT (89±12°), however, the endocardial atrial layer located above the 
SAN exhibited a wide range of dominant fiber angles (36-128°) between specimens.  
Within each specimen, there was still a strong tendency for the endocardial atrial layer 
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above the SAN to exhibit unidirectional fiber orientation as in Figure 4.5D-F.  The 
overall average angle of the SAN itself was relatively consistent among the specimens at 
110±16°, however each individual specimen did exhibit a high degree of fiber disarray 
within the node, such as that illustrated in Figure 4.5G-I.  The amount of fiber disarray 
was evaluated based on the standard deviation of angles within each structure (CT, 
endocardial atrial layer, and SAN) as shown in Figure 4.7.  Overall, the SAN 
demonstrated significantly higher standard deviations (33±7°) than both the endocardial 
atrial layer (23±5°, p=0.02) and the CT (18±3°, p=0.0003) indicative of its higher degree 
of fiber disarray. 
 
 
 
Figure 4.6:  Average fiber angle.  Average fiber angles across all hearts in three 
locations: the atrium (endocardial to the SAN), SAN, and CT. 
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Figure 4.7: Standard deviation of the average fiber angle.  Standard deviation of the 
average fiber angle as an indicator of fiber disarray across all hearts in three locations: 
the atrium (endocardial to the SAN), SAN, and CT. 
 
 
 
4.4.3 Fiber Orientation in the Block Zone 
 
 
In addition to evaluating fiber orientation in the CT, endocardial atrium, and SAN, fibers 
were also identified with unique orientation patterns in the block zone (Boyett, Honjo et 
al. 2000) as shown in Figure 4.8.  The bright white area, as indicated by the white arrow 
in Figure 4.8C, most likely contributes to the functional block zone, as shown in Figure 
4.8A.  The pattern of fibers indicated by the red arrow in Figure 4.8E appear to “dead-
end” in the block zone.  Consequently, an impulse originating from the SAN would not 
be able to traverse these fibers and would instead have to bypass the block zone, as 
indicated by the dotted white line in Figure 4.8E, in order to excite the remaining bulk of 
atrial tissue. 
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Figure 4.8: (A) Photograph of an SA nodal preparation as viewed from the endocardium 
with the OCT field of view for the functional SA nodal block zone indentified by the white 
box.  OCT images of fiber orientation are shown at (B) 0.07 mm, (C) 0.12 mm, (D) 0.18 
mm, (E) 0.24 mm, (F) 0.32 mm, and (G) 0.42 mm below the endocardium.  The white 
arrow in (C) indicates the probable anatomic correlate of the functional block zone.  The 
dotted white lines indicate the pathways for impulse propagation around the block zone.  
The red arrow indicates fibers that “dead-end” in the functional block zone.  
Abbreviations – SVC: superior vena cava; IVC: inferior vena cava; RAA: right atrial 
appendage; IAS: interatrial septum. 
 
 
 
4.5 Discussion 
 
 
It is well known that cardiac function is intimately linked to underlying tissue structure.  
In this study, we had the distinct advantage of performing structurally-based imaging on 
electrophysiologically-characterized preparations.  We focused specifically on the 
structure-function relationship in the canine SAN with particular emphasis on fiber 
orientation patterns as they relate to SA nodal conduction.  Our previous study 
functionally identified the block zone, nodal tissue, and discrete exit pathways in the 
canine heart (Fedorov, Schuessler et al. 2009).  In addition, these structures were also 
identified using more traditional histological and immunohistochemical techniques.  Now 
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for the first time, we have demonstrated the existence of these structures using a 
nondestructive imaging modality. 
 
We have identified unique fiber orientation patterns specific to the CT (Figure 4.3), SAN 
(Figure 4.4), atrial myocardium (Figures 4.3 and 4.4), and block zone (Figure 4.8).  In 
addition, we quantified fiber orientation distributions, using an automated gradient-based 
algorithm (Fleming, Ripplinger et al. 2008), in these areas (Figure 4.5).  We found that 
the CT and atrial myocardium tended to display unidirectional fiber orientations, whereas 
the SAN exhibited an increased amount of fiber disarray manifested as a significantly 
greater standard deviation in fiber angle distributions (Figure 4.7).  Although we were 
unsuccessful in concretely identifying the exit pathways using OCT, we believe their 
presence may be masked by surrounding fibers with similar orientation patterns.  We 
were, most importantly, able to distinguish SA nodal tissue from the surrounding atrial 
myocardium (Figures 4.4, 4.5, and 4.7).   
 
In addition to being a key component of normal cardiac conduction, the atrial pacemaker 
complex, consisting of the SAN, block zone, exit pathway(s), and surrounding atrial 
myocardium, has also been shown to be involved in arrhythmias, such as atrial flutter and 
fibrillation (Fedorov, Schuessler et al. 2009; Fedorov, Chang et al. 2010).  These 
arrhythmias are oftentimes associated with SA nodal dysfunction (Schuessler 2003) and, 
more importantly, are accompanied by both functional and structural changes in the SAN 
(Sanders, Morton et al. 2004).  Structural changes, such as alterations in interstitial 
fibrosis (Ausma, Wijffels et al. 1997), within the SAN could potentially be monitored 
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over time with high spatial resolution OCT, as an indicator of disease progression.  In 
addition, an increased amount of fibrosis or abrupt changes in fiber orientation patterns 
may result in a higher propensity for reentrant arrhythmias (Valderrabano, Lee et al. 
2001).   
 
Recently, it has been suggested that there is a unique structure running parallel to the 
human SAN termed the paranodal area (Chandler, Greener et al. 2009; Chandler, 
Aslanidi et al. 2011).  This region was shown to have unique molecular and histological 
characteristics in the human heart, with properties intermediate between the SAN and 
normal right atrial myocardium.  In our study, we were unable to identify this area in the 
canine heart using both traditional histology and OCT, despite the functional similarities 
we have found between the human and canine SANs (Fedorov, Schuessler et al. 2009; 
Fedorov, Glukhov et al. 2010).  The identification of the paranodal area in the human 
heart with OCT still remains to be explored. 
 
OCT is a nondestructive imaging technique with superior spatial resolution as compared 
to other anatomical visualization and reconstruction techniques (Povazay, Bizheva et al. 
2002; Fujimoto 2003).  Most importantly, OCT can be miniaturized into a catheter-based 
imaging system (Tearney, Brezinski et al. 1996; Fleming, Wang et al. 2010) to be 
threaded through the vasculature and into the cardiac chambers.  In this way, physicians 
can directly relate, in real time and in situ, cardiac function to its underlying structure 
during electrophysiology studies and ablation procedures.  In addition, the continued 
development of automated visualization and analysis tools (Fleming, Ripplinger et al. 
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2008; Hucker, Ripplinger et al. 2008) for OCT will only serve to power its movement 
into mainstream cardiology. 
 
 
4.6 Conclusion 
 
 
We have demonstrated the ability of OCT in detecting components of the atrial 
pacemaker complex, which are intimately involved in both normal and abnormal cardiac 
conduction.  We identified and quantified fiber orientation patterns specific to the CT, 
SAN, atrial myocardium, and block zone using an automated gradient-based algorithm.  
Based on this study, we believe OCT is continuing to emerge as a key imaging modality 
with the potential to identify, in real time and in situ, structural substrates responsible for 
both normal and abnormal cardiac conduction. 
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5 Termination of Sustained Atrial Flutter and 
Fibrillation Using Low-Voltage Multiple-Shock 
Therapy 
 
 
 
5.1 Abstract 
 
 
Defibrillation therapy for atrial fibrillation (AF) and flutter (AFl) is currently limited by 
the pain induced by high-energy shocks.  Thus, lowering the defibrillation energy for 
AFl/AF is highly desirable.  In this study, we applied low-voltage multiple-shock therapy 
in a rabbit model of atrial tachyarrhythmias comparing its efficacy to single shocks and 
antitachycardia pacing (ATP).  Optical mapping was performed in Langendorff-perfused 
rabbit hearts (n=18).  Acetylcholine (7±5 to 17±16 µM) was administered to promote 
sustained AFl and AF, respectively.  Single and multiple (3-8) monophasic shocks were 
applied within 1 or 2 cycle lengths (CLs) of the arrhythmia.  We observed AFl (CL = 
83±15 ms, n=17) and AF (CL = 50±8 ms, n=11).  ATP had a success rate of 66.7% in the 
case of AFl, but no success with AF (n=9).  Low-voltage multiple shocks had 100% 
86 
success for both arrhythmias.  Multiple low-voltage shocks terminated AFl at 0.86±0.73 
V/cm (within 1 arrhythmia CL) and 0.28±0.13 V/cm (within 2 arrhythmia CLs), as 
compared with single shocks at 2.12±1.31 V/cm (p<0.001) and AF at 3.46±3 V/cm 
(within 1 arrhythmia CL), as compared with single shocks at 6.83±3.12 V/cm (p=0.06).  
For multiple shocks delivered within one CL, 4 shocks resulted in the lowest 
defibrillation threshold for both AFl and AF (0.41±0.22 and 1.97±1.25 V/cm, 
respectively).  Additionally, despite the fact that multiple shocks delivered within 2 CLs 
resulted in the lowest defibrillation threshold for AFl (0.28±0.13 V/cm), this therapy also 
resulted in an increased conversion rate of AFl to sustained AF.  No ventricular 
arrhythmias were induced.  Optical mapping revealed that termination of AFl was 
achieved by a properly timed, local shock-induced wave that collides with the arrhythmia 
wavefront, whereas AF required the majority of atrial tissue to be excited and reset for 
termination.  Low-voltage multiple-shock therapy terminates AFl and AF with different 
mechanisms and thresholds based on spatiotemporal characteristics of the arrhythmias. 
 
 
5.2 Introduction 
 
 
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the world, affecting 
over 2.2 million people in the United States (Lloyd-Jones, Adams et al. 2010).  A recent 
population study estimates that by the year 2050, over 12 million Americans may be 
affected (Miyasaka, Barnes et al. 2006).  Complications of AF include thromboembolic 
stroke, congestive heart failure, and increased mortality (Crandall, Horne et al. 2009; 
Seiler and Stevenson 2010).  In addition, AF leads to more hospitalizations than any other 
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arrhythmia, resulting in a significant socioeconomic burden (Coyne, Paramore et al. 
2006; Kannel and Benjamin 2009).  Treatment strategies, including drug therapy, 
cardioversion, and ablation, are designed to reduce the frequency and duration of 
arrhythmia episodes as it is known that AF begets AF (Wijffels, Kirchhof et al. 1995).  
Furthermore, AF can be classified as a progressive disease and, if left untreated, 
paroxsysmal AF can degenerate into permanent AF (Cohen and Naccarelli 2008), and 
atrial flutter (AFl) can degenerate into AF (Waldo and Feld 2008). 
 
Options for drug therapy include quinidine and flecainide, however, these and other 
available antiarrhythmic drugs have potentially serious side effects and low efficacy 
(Nattel 1998; Dobrev and Nattel 2010).  A newly-developed generation of anti-
arrhythmic drug therapy could be effective, but still needs further clinical validation 
(Dobrev and Nattel 2010).  There have also been many advances in ablative techniques 
(Lee, Melby et al. 2009); yet, these procedures are not without risks, including, but not 
limited to, esophageal injury, phrenic nerve injury, and pulmonary vein stenosis 
(Doppalapudi, Yamada et al. 2009).  In addition, ablation of atrial tachyarrhythmias has 
yet to become a standardized procedure and, consequently, there is a wide variation in 
published success rates that can be both physican- and medical center-dependent 
(Calkins, Reynolds et al. 2009). 
 
Antitachycardia pacing (ATP) delivers a train of stimuli coordinated with the arrhythmia 
cycle length (CL) that attempts to disrupt the aberrant circuit(s) maintaining AF or AFl; 
however, its success rates are often around, or significantly less than 60% (Gillis, Koehler 
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et al. 2005).  Cardioversion delivers an electric shock designed to reset all cardiac 
electrical activity and clinical trials have shown its success to be higher when applied to 
shorter arrhythmia episodes (Van Gelder, Crijns et al. 1991; Coro, Delise et al. 2001).  
External cardioversion boasts success rates up to 97% (Koster, Dorian et al. 2004), but 
requires high-shock energies and sedation of the patient.  In addition, high energy shocks 
can cause electroporation (Fedorov, Kostecki et al. 2008) and atrial stunning (Khan 
2003), leading to an increased risk of thrombus formation and cardiac damage.  On the 
other hand, the use of intracardiac shocks, by the implantable atrial defibrillator (IAD) 
(Dosdall and Ideker 2007), requires less energy and patient sedation (Alt, Ammer et al. 
1997).  Although initial clinical trials have shown that the IAD has a high specificity and 
sensitivity to AF and delivers safe and effective shocks (Schoels, Swerdlow et al. 2001), 
it has not gained widespread acceptance because the energy for successful endocardial 
cardioversion still exceeds the pain threshold (Mitchell, Spurrell et al. 2004).  Thus, 
lowering the defibrillation energy for atrial arrhythmias is highly desirable.   
 
In a recent study, we applied a method for low-voltage termination of ventricular 
tachycardia in a rabbit whole heart model and found a significant reduction in the 
defibrillation threshold (Li, Ripplinger et al. 2009).  In this study, we aim to apply this 
therapy to a rabbit model of AFl and AF.  Our technique of low-voltage multiple-shock 
therapy is based on the virtual electrode polarization (VEP) hypothesis (Efimov and 
Ripplinger 2006), and is a method of destabilizing and terminating anatomically-defined 
reentrant tachyarrhythmias (Ripplinger, Krinsky et al. 2006).  This technique utilizes a 
lower voltage shock that serves to unpin the core of the arrhythmia’s mother rotor, which 
89 
has anchored itself to a physical myocardial heterogeneity (Takagi, Pumir et al. 2004; 
Ripplinger, Krinsky et al. 2006).  The core of reentry will experience a greater 
polarization in response to the applied electric field according to the VEP hypothesis.  
The depolarized region of the reentry core then becomes a secondary source of excitation, 
which can create a new wave.  When timed correctly, the new wave can collide with and 
either terminate or unpin the anatomical reentry.  If unpinned, the reentry will become 
unstable and self-terminate.  In this study, we now aim to apply this technique to a rabbit 
model of cholinergically-induced AFl/AF and by applying multiple shocks within 1-2 
arrhythmia CLs, we aim to increase the probability of a shock falling within the optimal 
time frame for successful termination. 
 
In applying low-voltage multiple-shock therapy, important distinctions between AFl and 
AF must be considered.  AFl is defined by a macro-reentrant circuit, which can rotate 
around an anatomic or functional line of block.  Major anatomical structures, including 
the region between the vena cavae and pulmonary veins are usually involved in defining 
reentry (Fedorov, Chang et al. 2010).  AF, on the other hand, involves multiple reentrant 
circuits defined primarily by local excitability and refractory periods.  In this study, we 
hypothesize that low-voltage multiple-shock therapy will terminate anatomically-defined 
AFl with higher efficacy than functionally-defined AF because of its ability to efficiently 
penetrate the longer excitable gap associated with AFl and consequently, to unpin 
reentry. 
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5.3 Materials and Methods 
 
 
5.3.1 Experimental Preparation 
 
 
The experimental protocol was approved by the Institutional Animal Care and Use 
Committee of Washington University.   
 
Experiments were performed in vitro on hearts obtained from New Zealand white rabbits 
(n=18) of both sexes.  The isolation procedure has been described previously (Fedorov, 
Lozinsky et al. 2007).  Briefly, rabbits were anesthetized intravenously with 50 mg/kg 
sodium pentobarbital and 1,000-2,000 U heparin.  The heart was removed and placed 
onto a Langendorff apparatus, where it was coronary-perfused at 20 mL/min with 
oxygenated Tyrode’s solution.  Fat and connective tissue was carefully dissected from the 
posterior epicardium of the heart and all vena cavae and pulmonary veins were ligated.  
Perfusion fluid flowing out of the coronary sinus into the right ventricle exited the heart 
exclusively through a cannula in the pulmonary artery.  In addition, the interatrial septum 
was perforated, allowing for equal pressures in both atria and a more uniform epicardial 
surface for optical mapping.  The whole heart preparation was then placed posterior side 
up in a temperature-controlled bath (Radnoti, Monrovia, California) at 37°C and 
Langendorff-perfused under a constant pressure of 60 mmHg with oxygenated Tyrode’s 
solution.  The excitation-contraction uncoupler blebbistatin (Tocris Biosciences, 
Ellisville, Missouri) was added to the perfusate at 10 µM to suppress motion artifacts in 
the optical recordings (Fedorov, Lozinsky et al. 2007).  The heart was then stained with 
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the voltage-sensitive dye, di-4-ANEPPS (Molecular Probes, Eugene, Oregon), diluted in 
dimethylsulfoxide (Sigma-Aldrich, St. Louis, Missouri). 
 
 
5.3.2 Optical Mapping and Defibrillation Setup 
 
 
During a 20-30 minute equilibration period, bipolar electrodes, which could be switched 
between pacing and sensing without disrupting their original positions, were placed on 
the left atrial appendage (LAA), right atrial appendage (RAA), and right atrial (RA) free 
wall.  Two stainless steel mesh electrodes were placed vertically into the solution 
chamber approximately 10 cm apart parallel to the long axis of the heart.  Shocks were 
deliver from two computer-controlled regulated power supplies (BOP 100-4M1; Kepko, 
Inc., Flushing, New York) connected in parallel to provide a maximum voltage of ±100V 
and a maximum current of 8A as described previously (Ripplinger, Lou et al. 2009).   
 
Optical mapping was performed with a 100x100 pixel MiCAM Ultima-L CMOS camera 
(SciMedia, Costa Mesa, California).  The preparation was illuminated by light-emitting 
diodes at 520 nm and fluorescence emitted from the preparation was long-pass filtered 
above 610 nm.  Optical action potentials (OAPs) were recorded from a field of view of 
approximately 30x30mm2, which was sufficient to encompass both atrial appendages, 
with a spatial resolution of 300 µm at a frame rate of 1000 frames/sec.  The resultant 
fluorescent signals were amplified, digitized, and visualized during the experiment using 
specialized software (SciMedia, Costa Mesa, California).   
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5.3.3 Experimental Protocol 
 
 
After optimization of the optical signals, the intrinsic activity of each preparation was 
recorded.  Pacing thresholds and effective refractory periods (ERPs) were determined 
from all locations.  All stimuli were subsequently delivered at 2-3x the pacing threshold.  
Far field stimulation thresholds as a result of shocks were also determined for both 
polarities (n=7). 
 
After all control variables were obtained, programmed stimulation was applied to attempt 
to initiate an arrhythmia by a Master-8 programmable stimulator (A.M.P.I., Jerusalem) 
and a custom-written stimulation interface (see Appendix 2).  Programmed stimulation 
consisted of either an S1-S2 protocol (10-20 basic stimuli at 300 ms followed by a 
premature beat at progressively shorter coupling intervals) or burst pacing.  If arrhythmia 
initiation was unsuccessful, incremental concentrations of acetylcholine chloride (ACh, 
1-100 µM; Sigma-Aldrich, St. Louis, Missouri) were added until a sustained arrhythmia 
was induced (Sharifov, Fedorov et al. 2004).  A sustained arrhythmia was defined as 
lasting at least 2-3 minutes, although if not terminated, the arrhythmias would persist on 
the order of one hour.  Single or multiple (3-8) 5-10 ms monophasic shocks were applied 
equally spaced out within either one or two CLs of the arrhythmia (n=18).  In addition, 
we also applied ATP consisting of 8 pulses at 50-100% of the arrhythmia CL from either 
the RAA or lower RA (n=9).  If the arrhythmia was terminated by either the shock or 
ATP, a new arrhythmia was immediately reinitiated via the programmed stimulation 
described earlier.  Success was defined as termination of the arrhythmias within three 
seconds of therapy applications. 
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5.3.4 Data Analysis 
 
 
A custom-designed MATLAB-based computer program, described previously (Fedorov, 
Chang et al. 2010), was used to analyze experimental data offline.  Activation maps were 
constructed from activation times calculated from the dV/dtmax of each pixel.  
Quantitative data are expressed as mean ± standard deviation.  The Student’s t-test was 
used to determine statistical significance (p<0.05). 
 
 
5.4 Results 
 
 
5.4.1 Initiation of Arrhythmias 
 
 
Figure 5.1a shows an optical mapping field of view encompassing the posterior side of 
the atria, including both the RAA and LAA.  Figure 5.1b shows an example activation 
map while pacing the RAA (CL=300 ms), with the corresponding OAPs shown in Figure 
5.1c.  Upon addition of an ACh concentration needed for the induction of a sustained 
arrhythmia, the atrial ERP was reduced from 67±11 ms to 40±8 ms (p<0.001) (Figure 
5.1d).  Figure 5.1e illustrates the significant shortening of the action potential duration, 
establishing the functional substrate necessary for inducing and maintaining AFl/AF. 
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Figure 5.1: Low-voltage multiple-shock defibrillation experimental setup.  (a) 
Photograph of a typical preparation with shock meshes labeled, located 10 cm apart.  
The black circles represent the locations of pacing/sensing electrodes.  (b,c) Typical 
activation map and OAPs during pacing of the RAA (300 ms).  The deep blue areas in the 
center represent pixels that have been excluded from analysis because of noise from 
sutures and connective tissue.  (d) Average ERP before and after ACh.  (e) 
Representative OAPs from the RAA before and after the addition of 5 µM ACh, reflecting 
a 57% decrease in the action potential duration.  Abbreviations – ACh: acetylcholine 
chloride; ERP: effective refractory period; IVC: inferior vena cava; LAA: left atrial 
appendage; LSVC: left superior vena cava; OAP: optical action potential; PV: 
pulmonary vein; RA: right atrium; RAA: right atrial appendage; RV: right ventricle; 
SVC: superior vena cava. 
 
Upon addition of 7±5 µM ACh, we induced AFl maintained by a single macro-reentrant 
circuit (CL = 83±15 ms, n=17) rotating around the anatomic zone of conduction block 
between the superior and inferior vena cava (Figure 5.2a).  Figure 5.2b shows that AF 
was maintained by multiple reentry circuits (CL = 50±8 ms, n=11) with an average ACh 
concentration of 17±16 µM.  Dominant frequency analysis reflected the major rotors 
maintaining each arrhythmia as illustrated in Figure 5.2c,d.  In only one heart out of 18 
were we unable to induce any sustained arrhythmias even with the addition of 500 µM 
ACh.  Additionally, in three preparations we were able to initiate AFl before the addition 
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of ACh, although the arrhythmias were sustained enough in only two preparations in 
which we performed limited defibrillation testing. 
 
Figure 5.2: Typical atrial flutter and fibrillation.  (a,b) Typical activation maps, 
representative of 1 arrhythmia cycle, and OAPs (as indicated by the black squares) of 
AFl and AF, respectively.  Dashed black lines with arrows show the location and 
direction of the reentrant circuits.  (c,d) Frequency distribution for typical examples of 
AFl and AF, respectively. 
 
 
5.4.2 Application of Antitachycardia Pacing 
 
 
ATP was applied in nine hearts from an electrode placed on either the RAA or lower RA, 
similar to clinical RA pacing leads.  We applied 107 rounds of ATP from both locations 
consisting of 8 pulses at 50-100% of the arrhythmia CL (Figure 5.3).  Figure 5.3b shows 
that 22.4% of ATP applications to AFl were successful in terminating the arrhythmia.  
However, 70.1% of applications had no effect on the arrhythmia and 7.5% of applications 
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converted AFl to AF.  Therapy applied at 80% of the arrhythmia CL had the highest 
likelihood of success (13/34 applications resulted in termination, p=0.0006), whereas 
ATP at 90% of the arrhythmia CL resulted in the highest incidence of failed termination 
(38/41 applications had no effect, p=0.0008).  As shown in Figure 5.3c, ATP was most 
successful in arrhythmias with longer average CLs (80-85 ms and 95-100 ms).  Overall, 
ATP successfully terminated arrhythmias in 6 out of 9 preparations (66.7%).  
Furthermore, the outcome of ATP was not dependent on electrode location and, as 
expected, ATP did not terminate any episodes of AF. 
 
Figure 5.3: Application of antitachycardia pacing to AFl.  (a) Representative 
electrograms of termination, failed termination, and conversion to AF upon application 
of ATP (8 pulses, 50-100% of arrhythmia CL) to AFl from the RAA and lower RA.  (b) 
Distribution of outcome during application of ATP to AFl.  (c) Percentage of therapy 
success as a function of CL.  Abbreviations – ATP: antitachycardia pacing; CL: cycle 
length; EGM: electrogram. 
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5.4.3 Far Field Excitation Threshold 
 
 
Prior to arrhythmia induction, we applied single shocks to determine the atrial far field 
excitation threshold (n=7).  Figure 5.4a,b show that shocks of opposite polarities resulted 
in identical atrial activation patterns.  Of seven preparations, four demonstrated activation 
patterns originating from the RAA; however, in two preparations the earliest activation 
began from the LAA, and in one preparation activity originated from the lower RA.  We 
observed no difference in the atrial far field excitation threshold when comparing 
opposite polarity shocks (0.097±0.06 V/cm for both) (Figure 5.4c).  Lower voltage 
shocks (i.e., 0.05 V/cm) resulted in physiological  activation of the ventricles via the 
atrioventricular node and conduction system, whereas higher voltage shocks (i.e., 5 
V/cm) resulted in simultaneous activation of both the atria and ventricles (Figure 5.4d,e).  
The ventricular far field excitation threshold was 0.43±0.13 V/cm. 
 
Figure 5.4: Far field excitation.  (a,b) Activation maps resulting from opposite polarity 
shocks at a field strength of ±0.05 V/cm.  The dotted black line demarcates the AV 
groove.  (c) Average shock field strength of both polarities (0.097±0.06 V/cm).  (d) 
Activation delay of the ventricles at a physiological AV delay (76 ms) caused by far field 
excitation of the atria with a shock field strength of 0.05 V/cm.  (e) Simultaneous 
activation of the atria and ventricles with a higher-voltage shock. 
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In the preparation illustrated in both Figure 5.2 and 5.4, the location of earliest activation 
(RAA; Figure 5.4a,b) corresponded with the location of the dominant rotor maintaining 
AF (RAA, Figure 5.2d).  This, however, was not representative of all experiments.  The 
dominant rotor corresponded to the site of earliest activation via far field shocks in only 
50% of the preparations in which both the threshold was measured and AF was induced. 
 
 
5.4.4 Termination of Atrial Flutter by Low-Voltage Multiple-Shock 
Therapy 
 
 
The efficacy of low-voltage multiple shock therapy was tested during AFl and AF, and 
then compared with both ATP and the application of single, phase-independent shocks.  
In the case of AFl, we applied a total of 405 trials of low-voltage multiple-shock therapy: 
302 trials were delivered within 1 CL of the arrhythmia and 103 trials were delivered 
within 2 CLs.  Figure 5.5a shows that the defibrillation threshold was significantly 
decreased during trials in which we applied multiple shocks within 1 CL (0.86±0.73 
V/cm) and 2 CLs (0.28±0.13 V/cm), as compared to single shocks (2.12±1.31 V/cm).  
Despite the significantly decreased defibrillation threshold for multiple shocks delivered 
over 2 CLs, this therapy resulted in an increased rate of conversion of AFl to sustained 
AF when compared with multiple shocks delivered over 1 CL (16.5% versus 14.2%, 
p=0.3).  Single shocks resulted in AF in 6.4% of therapy applications.  Additionally, 
54.3% of terminations in the case of multiple shocks delivered over 2 CLs were preceded 
by a short run of AF.  Overall, immediate termination of AFl occurred in 63% of cases, 
whereas 37% of terminations were preceded by a 1.46±0.8 second run of AF.  For 
multiple shocks delivered within 1 CL, 4 shocks resulted in the lowest overall 
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defibrillation threshold (0.41±0.22 V/cm), as compared to 3 (0.53±0.41 V/cm) and 5 
(1.26±0.82 V/cm) shocks (Figure 5.5b).  Preparations in which the length of our 
experimental protocol allowed for the testing of all numbers of multiple shocks also 
followed these more global observations as shown in Figure 5.6.  Defibrillation of AFl 
was successful by multiple shocks in 100% of the preparations in which the arrhythmia 
was induced. 
 
Figure 5.5: Defibrillation thresholds.  (a) Defibrillation thresholds for single shocks, 
multiple shocks delivered within 1 CL, and multiple shocks delivered within 2 CLs.  (b) 
Defibrillation thresholds for single shocks and multiple shocks (3 to 5) delivered within 1 
arrhythmia CL for AFl and AF, respectively. 
 
 
Figure 5.6: Shock field strength as a function of number of shocks. 
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5.4.5 Termination of Atrial Fibrillation by Low-Voltage Multiple-
Shock Therapy 
 
 
In the case of AF, we applied a total of 233 trials of low-voltage multiple-shock therapy 
delivered within 1 CL of the arrhythmia.  Once again, defibrillation of AF by multiple 
shocks was successful in 100% of preparations and the defibrillation threshold was 
decreased (p=0.06) during the trials in which we applied multiple shocks within 1 CL 
(3.46±3 V/cm), as compared to the application of single shocks (6.18±3.12 V/cm) as 
shown in Figure 5.5a.  For multiple shocks delivered within 1 CL, 4 shocks again resulted 
in the lowest defibrillation threshold (1.97±1.25 V/cm), as compared to 3 (4.38±2.92 
V/cm) and 5 (4.97±2.08 V/cm) shocks in this arrhythmia model (Figure 5.5c). 
 
Figure 5.7 shows the average CLs of AFl and AF, which were successfully defibrillated 
during the course of the study, as a function of defibrillation threshold.  There is a trend 
that AFl with longer CLs, require lower shock strengths for defibrillation, however the 
trend for defibrillation of AF is not as clear. 
 
Figure 5.7: Defibrillation threshold as a function of arrhythmia cycle length. 
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5.4.6 Mechanisms of Termination 
 
 
Optical data obtained during the application of multiple shocks to AFl and AF revealed 
that the mechanism of termination relies on the recruitment of a sufficient number of 
secondary sources of excitation, resulting from virtual electrodes, to effectively terminate 
all reentrant circuits involved in the arrhythmia.  Due to the fact that the maintenance of 
AFl and AF require different numbers of reentrant circuits, the energy needed to create a 
sufficient amount of secondary sources varies between the arrhythmias.  In addition to the 
field strength of the shock, the timing of the shock is also important (Ripplinger, Krinsky 
et al. 2006). 
 
The termination of AFl was achieved through unpinning of the arrhythmia wavefront by 
a properly timed shock arising from the location of earliest activation corresponding to 
the region of highest anatomical heterogeneity (Trayanova, Skouibine et al. 1998).  In the 
example of successful termination shown in Figure 5.8a,b the train of multiple shocks 
was delivered approximately 7 ms earlier than the unsuccessful shock (Figure 5.8c,d) in 
relation to the rotating arrhythmia wavefront. 
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Figure 5.8: Application of multiple shocks to atrial flutter.  (a) In this example of 
successful arrhythmia termination, four 10 ms shocks (0.3 V/cm) were applied during 1 
CL of AFl (70 ms).  OAPs are shown from the RAA and LAA before and after 
termination.  (b) Activation maps reconstructed from the dV/dtmax of the OAPs denoted by 
1 to 3 in (a).  (c) In this example of unsuccessful arrhythmia termination, five 10 ms 
shocks (0.25 V/cm) were applied during 1 CL of the same arrhythmia.  (d) Activation 
maps reconstructed from the OAPs denoted 1 to 3 in (c).  The asterisks (*) in (b,d) 
represent the shocks indicated in (a,c). 
 
The termination of AF was achieved by higher strength shocks able to excite and 
consequently to recruit enough secondary sources to disrupt the multiple rotors 
maintaining the arrhythmia.  As shown in Figure 5.9, successful and unsuccessful 
terminations of AF relied on the amount of tissue depolarized by one or more shocks in 
the delivered therapy.  In a dramatic example of successful termination of AF, as shown 
in Figure 5.9a, the first and fourth shocks (10 V/cm) in the series recruited atrial tissue in 
opposing areas as can be seen at 750 and 800 ms.  In this preparation, a shock of <10 
V/cm was not sufficient to defibrillate sustained AF.  In the example of unsuccessful 
termination of AF, as shown in Figure 5.9b, from a different preparation, the shocks 
delivered at 2 V/cm were not strong enough to engage a sufficient amount of atrial tissue 
and create enough secondary sources for termination.  Consequently, the arrhythmia 
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continued to persist after the shock (Gray, Ayers et al. 1997).  Subsequent multiple shock 
therapy applications in this preparation terminated AF at 6 V/cm. 
 
Figure 5.9: Application of multiple shocks to atrial fibrillation.  (a) In this example of 
successful arrhythmia termination, four 10 ms shocks (10 V/cm) were applied during 1 
arrhythmia CL of AF (55 ms).  OAPs are shown from the RAA and LAA before and after 
termination by the shocks shown.  Arrhythmia wavefronts, reconstructed from the 
dV/dtmax, before, during, and after shock application.  (b) In this example of unsuccessful 
termination, three 10 ms shocks (2 V/cm) were applied during 1 CL of AF (50 ms).  
Arrhythmia wavefronts before, during, and after shock application.  Arrhythmia 
wavefront frames indicated by red lettering represent those reconstructed during shock 
application. 
 
5.4.7 Therapy Safety 
 
 
During the application of a total of 638 rounds of low-voltage multiple-shock therapy in 
17 preparations, no episodes of ventricular flutter of fibrillation were induced.  In 
addition, there was no evidence of atrial electroporation as the majority of shocks were 
delivered below the atrial electroporation threshold (9.2-13.6 V/cm) (Fedorov, Kostecki 
et al. 2008). 
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5.5 Discussion 
 
 
In the present study, a new method of low-voltage multiple-shock therapy was tested in a 
rabbit model of atrial tachyarrhythmias.  We found a significant reduction in the 
defibrillation thresholds for both AFl and AF, as compared with single phase-independent 
shocks, and success rates of 100% as opposed to 66.7% and 0% with ATP for AFl and 
AF, respectively.  Furthermore, 4 shocks delivered within 1 CL showed the lowest 
defibrillation threshold for both arrhythmias. 
 
 
5.5.1 Antitachycardia Pacing 
 
 
The low success rate of ATP in our study, as compared with the 100% success rate of 
multiple-shock therapy, can be explained by the inability of local excitation to invade the 
excitable gap of reentry when the pacing electrode is not located close to the core of 
reentry.  On the other hand, multiple-shock therapy, based on the virtual electrode 
polarization hypothesis (VEP) (Efimov and Ripplinger 2006), uses far field electrical 
stimuli to produce excitation in larger areas of tissue to destabilize and terminate 
reentrant tachyarrhythmias (Ripplinger, Krinsky et al. 2006).  VEP predicts that, in 
response to an external electric field, opposite sides of functional and anatomical 
heterogeneities will experience either hyperpolarization or depolarization (Takagi, Pumir 
et al. 2004; Ripplinger, Krinsky et al. 2006).  The depolarized region of the heterogeneity 
can then become a secondary source of excitation and collide with the existing reentry, 
resulting in termination. 
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5.5.2 Monophasic versus Biphasic Shocks 
 
 
All shocks delivered in this study were monophasic, chosen because of the results of our 
previous investigation of ventricular tachycardia in a rabbit model of infarction (Li, 
Ripplinger et al. 2009).  In that study, it was reported that the use of monophasic shocks 
not only reinforced the VEP response of the tissue, but also terminated ventricular 
tachycardia with significantly lower energies than multiple biphasic shocks.  More 
importantly, it was found that the second phase of biphasic shocks reversed the VEP 
effect of the first phase, preventing maintenance of the secondary source of excitation 
responsible for colliding with and terminating the arrhythmia wavefront. 
 
 
5.5.3 Arrhythmia Organization and Defibrillation 
 
 
The spatiotemporal organization of AFl/AF is important to defibrillation studies.  Several 
different animal models of the arrhythmias, based on human states of the disease, have 
been developed, reflecting differences in such characteristics as dominant frequency, 
organization, and electrical/structural remodeling (Li, Fareh et al. 1999; Verheule, Wilson 
et al. 2003; Sharifov, Fedorov et al. 2004; Katsouras, Sakabe et al. 2009).  Additionally, 
Everett, et al (Everett, Wilson et al. 2007) recently showed that higher defibrillation 
thresholds are directly related to arrhythmia models with higher dominant AF 
frequencies, such as the cholinergically-induced experimental model used in this study 
(Mandapati, Skanes et al. 2000).   
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In our study, with more anatomically defined AFl and more functionally defined AF, we 
reported increased defibrillation thresholds for AF as opposed to AFl.  The mechanisms 
of defibrillation, as revealed by our optical mapping studies, show that the defibrillation 
of AFl/AF relies on the ability of the therapy to infiltrate the excitable gap of reentry.  In 
the case of AFl, the long excitable gap associated with a single macro-reentrant circuit 
was easily penetrated by a properly timed shock originating from the region of highest 
heterogeneity (Figure 5.8).  AF, on the other hand, shows multiple smaller reentrant 
circuits with higher dominant frequencies, and consequently, smaller excitable gaps.  
Multiple-shock therapy, in this case, required larger voltage shocks to excite a sufficient 
amount of tissue to disrupt the multiple motors maintaining that reentry (Figure 5.9). 
 
 
5.5.4 Patient Pain Perception 
 
 
Studies investigating patient pain perception have shown that internal shocks >0.1 J are 
generally perceived as uncomfortable, although there is a wide variation in perception, 
perhaps because of varying autonomic tone, the presence of drugs, and the location of the 
shock electrodes (Ladwig, Marten-Mittag et al. 2003; Mitchell, Spurrell et al. 2004).  
Additionally, the majority of patients are unable to distinguish the difference among 
shocks delivered higher than this threshold (Mitchell, Spurrell et al. 2004).  During 
clinical studies in which several intracardiac shocks were delivered about 5 minutes 
apart, patients perceived later shocks in the series to be more painful than the initial one 
regardless of the energy delivered (Steinhaus, Cardinal et al. 2002).  Clinical testing 
should be performed to determine how a train of multiple shocks delivered in quick 
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succession will be perceived, as the overall energy delivered may exceed that of a single 
shock. 
 
 
5.5.5 Safety 
 
 
In our study of the intact heart, we induced no episodes of ventricular tachyarrhythmias.  
As AFl/AF ranged from 50 to 200 ms in our experimental rabbit arrhythmia model, we 
have the ability to deliver low-voltage multiple-shock therapy safely and effectively 
within the ventricular refractory period without causing additional arrhythmias (Cheng, 
Li et al. 2004).  Human AFl/AF has been reported to range from 120 to 200 ms 
(Haissaguerre, Sanders et al. 2004; Kim, Olgin et al. 2009), while the ventricular 
refractory period is ≥200 ms (Kong, Goldberger et al. 1995).  Moreover, the AFl 
defibrillation threshold with multiple shocks delivered within 2 CLs was only 0.28±0.13 
V/cm and thus about 1.5 times less than the ventricular excitation threshold (0.43±0.13 
V/cm).  Consequently, additional in vivo experiments should be performed to evaluate 
this therapy in humans because low-strength atrial defibrillation shocks have been shown 
to excite the ventricles (Gray and Jalife 1998), and depending on the arrhythmia, may fall 
within the ventricular refractory period. 
 
A recent study by Fenton, et al proposed and tested a therapy termed “far field 
antifibrillation pacing” in a canine model of atrial tachyarrhythmia (Fenton, Luther et al. 
2009).  The therapy, 5 shocks, was applied to coincide with the CL of the arrhythmia in 
an attempt to synchronize tissue activation and create enough secondary sources of 
excitation for termination of the arrhythmia.  The investigators reported a success rate of 
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93% amongst 74 therapy trials in 8 coronary-perfused RA/RV preparations at field 
strengths of 0.9-1.4 V/cm.  Since far field shocks were applied at the CL of the 
arrhythmia, shocks could coincide with the T-wave to induce ventricular arrhythmias in 
the whole heart (Gray and Jalife 1998), although none were reported in this study.  In our 
study in the intact heart, we also observed no episodes of ventricular tachyarrhythmias.  
Furthermore, our ability to deliver low-voltage multiple-shock therapy during the 
ventricular refractory period ensures that we can safely and effectively terminate AFl/AF 
without causing additional arrhythmias, or the R-on-T phenomenon.   
 
It should also be mentioned that in the Fenton, et al study atrial tachycardia, AFl, and AF 
were not separated into distinct defibrillation trials making comparison between our 
studies difficult.  In addition, our recent canine atrial defibrillation study performed on 
the analogous AF canine model in the Fenton, et al study, demonstrated that the single 
shock defibrillation threshold was significantly lower for AFl versus AF (0.19±0.05 
versus 7.26±3.94 V/cm, p<0.05) (Foyil, Fedorov et al. 2008).  Consequently, as we have 
shown in this study, AFl and AF have distinct spatiotemporal characteristics resulting in 
varying defibrillation strengths and mechanisms. 
 
 
5.6 Conclusion 
 
 
Our findings indicate that low-voltage multiple-shock therapy has the potential to serve 
as a useful treatment for atrial tachyarrhythmias such as AFl and AF.  In this study, we 
have shown that multiple shocks delivered over 1 or 2 CLs significantly reduced the 
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defibrillation threshold of AFl and AF, although multiple shocks delivered over 2 CLs 
resulted in an increased conversion of AFl to AF.  We achieved defibrillation success in 
all preparations and induced no ventricular arrhythmias.  Based on this study, we 
conclude that low-voltage multiple-shock therapy terminates AFl with higher efficacy 
than AF due to the unique spatiotemporal characteristics of the arrhythmias. 
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6 Concluding Remarks and Future Directions 
 
 
The work presented in this dissertation sought to further understand the molecular and 
structural substrates of atrial fibrillation and flutter through the use of high-throughput 
molecular biology techniques (Chapter 2) and the application of optical coherence 
tomography (Chapters 3 and 4).  In Chapter 5, the low-voltage termination of these atrial 
tachyarrhythmias was addressed based on knowledge of their unique spatiotemporal 
characteristics. 
 
Since our recent investigations of ATP-sensitive potassium (KATP) channels (as described 
in Chapter 2, Section 2.4.3.1) revealed profound differences between molecular-level 
expression and their functional consequences in mouse and human hearts (Glukhov, 
Flagg et al. 2010; Fedorov, Glukhov et al. 2011), the use of clinically-relevant models of 
arrhythmia and disease pathology has become increasingly crucial.  Consequently, in this 
investigation we use a variety of animal models with proven clinical relevance.  The 
rabbit model, used for the low-voltage defibrillation studies presented in Chapter 5, has 
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been repeatedly shown to sustain clinically-relevant arrhythmias, which are typically not 
observed in other smaller animal species (Panfilov 2006).  The canine atrial pacemaker 
complex, as described in the study presented in Chapter 4, has been shown to functionally 
behave similar to the human heart (Fedorov, Schuessler et al. 2009; Fedorov, Glukhov et 
al. 2010) and furthermore is similar in size to the human heart.  Finally, we have been 
afforded the unique opportunity to work with human tissues, as presented in Chapters 2 
and 3, although careful consideration must be taken to account for disease pathology and 
other underlying factors that may confound experimental results. 
 
In Chapter 2, we analyzed relative expression levels of transcripts encoding for various 
ion channels, calcium handling proteins, and other transporters important in both normal 
and abnormal cardiac conduction as a function of both gender and disease pathology.  
While we probed tissues of both the left atrium and ventricle, significant patterns of 
gender dependent expression only appeared with respect to the atrium.  The 
pathophysiology of atrial fibrillation and congestive heart failure is, however, a complex 
interplay of long- and short-term molecular mechanisms that have only begun to be 
unraveled.  Continued access to and analysis of human cardiac tissues, such as those 
studied in this investigation will only serve to increase our understanding of these 
complex mechanisms.  Furthermore, as we have shown, the clinical classification of 
human tissues is critical in interpretation of results and factors, such as gender, disease, 
and arrhythmia history must be accounted for.   
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In this particular study, we analyzed the gene expression patterns in cardiac tissues with 
multiple distinct populations of cell types, including myocytes, fibroblasts, smooth 
muscle cells, and neuronal cells.  It is highly likely that these various cell types undergo 
differential remodeling processes and consequently express differential gene expression 
patterns as a function of gender, disease state, and arrhythmia history.  A recent study by 
Gronich, et al employed laser-capture microdissection in human cardiac tissue 
preparations to isolate the gene expression patterns of myocytes only (Gronich, Kumar et 
al. 2010).  Their study also focused on identifying alternative RNA splicing events, which 
could potentially play a key role with respect to gender and arrhythmia susceptibility and 
thus should be considered in future studies in this direction.  
 
An additional avenue of exploration in molecular cardiac excitability and 
arrhythmogenesis is the characterization of microRNAs.  MicroRNAs, composed of on 
average 22 nucleic acids, are post-transcriptional regulators that bind directly to mRNA 
resulting in translational repression and gene silencing.  Expression profiles of 
microRNAs have revealed significant differences in diseased and arrhythmic substrates 
pointing to their probable role in the pathogenesis of atrial fibrillation and heart failure 
(Wang 2010; Wang, Lu et al. 2011).  However, their role in the gender dependence of 
arrhythmia susceptibility and heart failure has yet to be elucidated. 
 
Finally, the availability of data sets, such as those produced in Chapter 2, incorporating a 
variety of tissues across age, gender, disease, and arrhythmia history, provides a wealth 
of information for computer modeling studies.  The development of physiologically-
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relevant models (Grandi, Pasqualini et al. 2010; O'Hara, Virag et al. 2011) relies upon the 
incorporation of clinically-relevant information.  In addition, computer models can 
potentially be used to predict electrophysiological behavior and provide the basis for 
simulations of drug therapy, for instance, in a wide variety of patient/disease types.  
 
In Chapters 3 and 4, we applied optical coherence tomography, a non-destructive, high-
resolution imaging modality, to a series of explanted human and canine hearts.  In both 
studies, we demonstrated the utility of OCT in imaging the cardiac conduction system 
and other structures crucial to cardiac conduction and arrhythmogenesis.  In the canine 
hearts, we specifically visualized and quantified cardiac fibers in the atrial pacemaker 
complex, which we have previously shown to be important in the maintenance and 
generation of atrial flutter and fibrillation (Fedorov, Chang et al. 2010).  We identified 
fiber orientation patterns unique to the crista terminalis, atrial myocardium, sinoatrial 
node, and block zone.  Furthermore, the fiber angle distributions of the crista terminalis, 
atrial myocardium, and sinoatrial node were able to be distinguished quantitatively. 
 
As we have shown in this dissertation, OCT has many potential applications in 
cardiology, particularly with respect to arrhythmia diagnostics and ablation guidance.  In 
addition, the development of catheter-based OCT probes has subsequently opened the 
door for uses beyond the realm of cardiac research.  A recent study by Fleming, et al 
demonstrated the utility of an OCT probe in monitoring the progress of radiofrequency 
ablation (Fleming, Wang et al. 2010).  Based on the studies presented in this dissertation, 
OCT can also be utilized, for example, to identify and/or monitor atrial fibroses and other 
114 
tissue heterogeneities that may play a role in the maintenance of reentrant atrial 
arrhythmias.  In addition, it may also be used for precise structural identification of the 
elements of the conduction system during electrophysiology studies and ablation 
procedures.  However, before OCT can be applied to clinical practice, several technical 
limitations must be addressed such as its limiting depth penetration (Bouma, Tearney et 
al. 1995) and imaging in blood-perfused tissues (Brezinski, Saunders et al. 2001; Xu, Yu 
et al. 2008).  
 
Finally, Chapter 5 presented a study in which we applied a method for low-voltage 
defibrillation therapy in a rabbit model of atrial tachyarrhythmias.  We demonstrated a 
significant reduction in defibrillation thresholds when applying multiple shocks within 
one and two arrhythmia cycle lengths to both atrial flutter and fibrillation.  We also used 
optical mapping to visualize the mechanisms of termination for both arrhythmias.  In this 
study, shocks were applied via far field shock meshes thus creating a uniform field 
strength across the heart.  In reality, clinical shock vectors may not encompass the entire 
heart and, subsequently, the mechanisms of defibrillation may be altered.  Consequently, 
it is critically important to test these defibrillation sequences in a large animal with 
clinically-positioned shock coils. 
 
One of the main goals of low-voltage defibrillation therapies is to reduce the overall 
defibrillation energy, as the energy required for successful endocardial cardioversion still 
exceeds the pain threshold (Mitchell, Spurrell et al. 2004).  Although studies have been 
completed exploring patient pain perception of multiple shocks, the shocks applied in 
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these studies were delivered on the order of minutes apart (Steinhaus, Cardinal et al. 
2002).  It remains to be seen how a train of multiple shocks delivered in quick succession, 
as delivered in this study, will be perceived.   
 
In summary, it is obvious from this dissertation and multitudes of other studies that atrial 
fibrillation is an extremely complex arrhythmia resulting from the interplay of a 
multitude of molecular, structural, and electrophysiological parameters.  Consequently, 
the development of efficacious treatment options is also complex and to date, no one 
therapy has been 100% successful in abolishing atrial fibrillation with minimal patient 
discomfort.  Only truly integrative approaches, such as those presented in this 
dissertation, combining efforts in molecular biology and both structural and functional 
imaging modalities, will continue to unravel the complexities of atrial fibrillation.  
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Appendix A Relative Quantification Data from Failing 
and Nonfailing Human Hearts of Both 
Genders 
 
 
 
This appendix contains the raw data, expressed as mean ± standard deviation, of the 
relative quantification (RQ values, 2-ΔΔCt) for all targets analyzed in this study.  An 
electronic version of this data will be made available upon publication.  Abbreviations are 
as follows – I F LA: ischemic female left atrium; I F LV: ischemic female left ventricle; I 
M LA: ischemic male left atrium; NF F LA: nonfailing female left atrium; NF F LV: 
nonfailing female left ventricle; NF M LA: nonfailing male left atrium; NF M LV: 
nonfailing male left ventricle; NF F Endo: nonfailing female left ventricular 
endocardium; NF F Epi: nonfailing female left ventricular epicardium; NF M Endo: 
nonfailing male left ventricular endocardium; NF M Epi: nonfailing male left ventricular 
epicardium; NI F Endo: nonischemic female left ventricular endocardium; NI F Epi: 
nonischemic female left ventricular epicardium; NI M Endo: nonischemic male left 
ventricular endocardium; and NI M Epi: nonischemic male epicardium.  
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Appendix B Master-8 Pacing and Acquisition Control 
Program 
 
 
The acquisition of data in Chapter 5 (Termination of Sustained Atrial Flutter and 
Fibrillation Using Low-Voltage Multiple-Shock Therapy) required the coordination of 
multiple experimental systems, including stimulation protocols, optical data acquisition, 
and shock delivery.  Consequently, a pacing and acquisition control program was 
designed using LabVIEW 7.1 (National Instruments) and a Master-8 programmable 
stimulator (A.M.P.I., Jerusalem).  In addition to delivering a variety of pacing protocols, 
the stimulator was also used to deliver appropriately-timed impulses to trigger both shock 
delivery and optical data acquisition as described in this Appendix.  
 
 
B.1 Components of the Low-Voltage Defibrillation Setup 
 
 
For the analysis performed in Chapter 5, we needed to be able to initiate arrhythmias, 
delivery therapy (in the form of both antitachycardia pacing and multiple monophasic 
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shocks), and record electrograms and changes in membrane fluorescence.  A Master-8 
programmable stimulator (A.M.P.I., Jerusalem) was used for overall coordination and 
delivery of a variety of pacing protocols.  A MiCAM ULTIMA-L CMOS camera system 
was used to record optical data and a dual Kepko-based defibrillator (Ripplinger, Lou et 
al. 2009) was used for shock delivery.  An overall schematic of the system is shown in 
Figure B.1. 
 
Figure B.1: Schematic of the overall experimental system for defibrillation study. 
 
The Master-8 programmable stimulator has a total of 8 independent channels capable of 
delivering repetitive, single, and train outputs with variable pulse durations, delays, and 
intervals.  Each channel delivers pulses ranging from -10 to +10 V with a maximum 
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current of 20 mA.  For this configuration, we use a total of five Master-8 channels for 
pacing and trigger delivery.  Channel 2 is used to trigger shock delivery.  Channel 3 is 
used to trigger the acquisition of optical data through the MiCAM Ultima-L system.  
Channels 6 through 8 are used to deliver various pacing protocols, including continuous 
pacing, burst pacing, and single and dual prematurities.       
 
 
B.2 LabVIEW Software Configuration 
 
 
B.2.1 User Interface 
 
 
The user interface for the pacing and acquisition control program is shown in Figure B.2.   
 
Figure B.2: User interface for LabVIEW program used to coordinate pacing protocols, 
shock delivery, and optical data acquisition. 
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As described previously, there are four pacing paradigms available to the user – 
Continuous Pacing (S1-S1), Burst Pacing, Single Prematurity (S1-S2) and Dual 
Prematurity (S1-S2-S3).  Each pacing paradigm is available with and without the option 
to simultaneously record optical data by triggering the MiCAM Ultima-L system.  When 
“Enable Acquisition” is checked, a low voltage TTL pulse (3.3 V) is delivered from 
channel 3 of the Master-8 to the MiCAM Ultima-L system according to the Advanced 
Data Acquisition Parameters located at the bottom of the LabVIEW interface.  If no 
pacing paradigms are enabled, acquisition will occur without delay.  
 
Once an arrhythmia is initiated and low-voltage multiple-shock therapy is ready to be 
delivered to the preparation through the stainless steel mesh electrodes located in the 
tissue bath, “Record Shock Application” should be checked on the LabVIEW user 
interface.  When this option is enabled, all other parameters associated with pacing 
protocols will be overwritten and the system will start by triggering data acquisition.  
Then at a specified Shock Delay (in ms) a TTL pulse (5.0 V) will be sent to the 
defibrillator to signal therapy delivery.  This ensures that appropriate optical recordings 
before, during, and after shock application are recorded. 
 
 
B.2.2 LabVIEW Code 
 
 
The underlying LabVIEW code for the pacing and acquisition control program consists 
of a nested series of loops differentially activated based on the parameters specified and 
options enabled on the program user interface.  Figure B.3 shows an example loop 
activated when Dual Prematurity (S1-S2-S3) is chosen as the pacing paradigm and 
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“Enable Acquisition” is activated.  Figure B.4 shows another loop activated when 
“Record Shock Application” is enabled. 
 
 
Figure B.3: LabVIEW block diagram for application of dual prematurity and optical 
data acquisition. 
 
 
Figure B.4: LabVIEW block diagram for delivery of defibrillation therapy and optical 
data acquisition. 
 
 
 
B.3 Conclusion and Additional Applications 
 
 
This Appendix describes the coordination of pacing protocols, optical data acquisition, 
and shock delivery using LabVIEW and a Master-8 programmable stimulator.  This 
experimental system was designed specifically for the study described in Chapter 5 of 
this dissertation, however variations on this particular system can provide mainstreamed 
data collection during complicated optical mapping experiments. 
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As described previously, the Master-8 stimulator has a total of 8 channels that can be 
programmed for a variety of applications.  For instance, it may be desirable to incorporate 
triggers into the system that will turn on light-emitting diodes necessary for optical data 
acquisition or to turn off perfusion/superfusion pumps so as not to record motion artifacts 
with optical data.  In addition, a trigger can also be incorporated to activate a National 
Instruments data acquisition card if a larger number of electrograms are to be recorded in 
a particular experiment. 
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